| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOA3 NCOA6 MAML1 ACTN4 MED13L DCC BCL9 NCOR1 KMT2D MTA3 YAP1 NR0B1 MAML2 MED23 NIPBL CNOT2 EP300 TP53BP1 SCAI | 5.15e-08 | 562 | 151 | 19 | GO:0003712 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.83e-07 | 18 | 151 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | chromatin binding | TPR NCOA3 NCOA6 POLR1A EP400 RBMXL1 ASH1L ACTN4 ISL1 PHC1 NCOR1 MLH3 MTA3 YAP1 TP63 RBMX MBD5 NIPBL EP300 CBX2 | 7.91e-07 | 739 | 151 | 20 | GO:0003682 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.98e-06 | 28 | 151 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | TPR NCOA3 NCOA6 MAML1 ACTN4 MED13L DCC BCL9 NCOR1 KMT2D SEPTIN3 MTA3 YAP1 SEPTIN14 TRIM17 FBXO42 NR0B1 MAML2 MED23 KIR2DS4 ANAPC7 NIPBL CNOT2 FKBP4 EP300 TP53BP1 SCAI | 3.27e-06 | 1356 | 151 | 27 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coactivator activity | NCOA3 NCOA6 MAML1 ACTN4 DCC BCL9 KMT2D MTA3 YAP1 MAML2 MED23 EP300 | 3.43e-06 | 303 | 151 | 12 | GO:0003713 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TPR NCOA3 NCOA6 MAML1 ACTN4 MED13L DCC BCL9 NCOR1 KMT2D MTA3 YAP1 TRIM17 FBXO42 NR0B1 MAML2 MED23 ANAPC7 NIPBL CNOT2 FKBP4 EP300 TP53BP1 SCAI | 6.56e-06 | 1160 | 151 | 24 | GO:0030674 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 8.30e-06 | 37 | 151 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.29e-05 | 187 | 151 | 9 | GO:0016922 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.70e-05 | 21 | 151 | 4 | GO:0042975 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.22e-05 | 118 | 151 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | protein domain specific binding | NCOA3 NCOA6 TCF12 UBQLN1 ISL1 XRCC4 DICER1 JAK2 PHAF1 NCOR1 UBE2I TP63 RBMX CEP250 NR0B1 TRPV4 AFDN NIPBL TP53BP2 | 3.46e-05 | 875 | 151 | 19 | GO:0019904 |
| GeneOntologyMolecularFunction | transcription factor binding | NCOA3 NCOA6 TCF12 FOXP2 ACTN4 ISL1 NCOR1 UBE2I YAP1 NR0B1 BSN CNOT2 FKBP4 EP300 TP53BP1 TP53BP2 DCP1A | 5.72e-05 | 753 | 151 | 17 | GO:0008134 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX19A DNAH3 MYH7 EP400 MYO6 DICER1 DNAH14 MLH3 CCT5 DNAH17 DDX25 NAV3 ASCC3 DNAH5 DNAH8 | 6.68e-05 | 614 | 151 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | NCOA3 NCOA6 TCF12 FOXP2 ACTN4 ISL1 NCOR1 UBE2I YAP1 NR0B1 FKBP4 EP300 TP53BP1 TP53BP2 | 1.39e-04 | 582 | 151 | 14 | GO:0140297 |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 1.71e-04 | 37 | 151 | 4 | GO:0043425 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.89e-04 | 70 | 151 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | NCOA3 NCOA6 FOXP2 ACTN4 ISL1 NCOR1 NR0B1 FKBP4 EP300 TP53BP1 TP53BP2 | 3.39e-04 | 417 | 151 | 11 | GO:0061629 |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 4.40e-04 | 20 | 151 | 3 | GO:0035259 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 4.40e-04 | 20 | 151 | 3 | GO:0042800 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPR LGMN MYH7 MYO6 TRPC5 APC ACTN4 LMOD3 PTPN4 NF1 CCT5 XIRP2 NAV3 TRPV4 AFDN TNS1 FKBP4 EP300 DCP1A | 6.44e-04 | 1099 | 151 | 19 | GO:0008092 |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 6.90e-04 | 53 | 151 | 4 | GO:0030331 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 1.96e-03 | 33 | 151 | 3 | GO:0050681 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.97e-03 | 441 | 151 | 10 | GO:0016887 | |
| GeneOntologyMolecularFunction | LIM domain binding | 1.98e-03 | 9 | 151 | 2 | GO:0030274 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 2.14e-03 | 34 | 151 | 3 | GO:0046966 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 5.95e-08 | 136 | 150 | 10 | GO:0030518 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 2.04e-07 | 155 | 150 | 10 | GO:0043401 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 2.33e-07 | 87 | 150 | 8 | GO:0033143 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | NCOA3 ACTN4 ISL1 JAK2 NCOR1 KMT2D TP63 RXFP2 NR0B1 CNOT2 FKBP4 EP300 | 2.34e-07 | 244 | 150 | 12 | GO:0009755 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | NCOA3 ACTN4 ISL1 JAK2 NCOR1 KMT2D TP63 NR0B1 CNOT2 FKBP4 EP300 | 2.75e-07 | 202 | 150 | 11 | GO:0141193 |
| GeneOntologyBiologicalProcess | regulation of intracellular estrogen receptor signaling pathway | 5.98e-06 | 36 | 150 | 5 | GO:0033146 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | EPHB2 LGMN CELF4 SYN3 MYO6 IQSEC2 DCC PTGS2 JAK2 NF1 SLC12A2 UBE2I PLPPR4 ARHGAP44 HRH1 AFDN BSN | 6.90e-06 | 663 | 150 | 17 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | EPHB2 LGMN CELF4 SYN3 MYO6 IQSEC2 DCC PTGS2 JAK2 NF1 SLC12A2 UBE2I PLPPR4 ARHGAP44 HRH1 AFDN BSN | 7.04e-06 | 664 | 150 | 17 | GO:0099177 |
| GeneOntologyBiologicalProcess | negative regulation of intracellular steroid hormone receptor signaling pathway | 1.02e-05 | 40 | 150 | 5 | GO:0033144 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 1.03e-05 | 239 | 150 | 10 | GO:0071383 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | NCOA3 UBQLN1 ACTN4 ISL1 SLC15A3 JAK2 NCOR1 KMT2D TP63 NR0B1 CNOT2 FKBP4 EP300 | 1.14e-05 | 416 | 150 | 13 | GO:0030522 |
| GeneOntologyBiologicalProcess | response to hormone | NCOA3 NCOA6 TCF12 APC ACTN4 ISL1 PTGS2 JAK2 NCOR1 KMT2D YAP1 TP63 RXFP2 NR0B1 SIK2 TRPV4 BCAR3 MBD5 CNOT2 FKBP4 EP300 | 2.19e-05 | 1042 | 150 | 21 | GO:0009725 |
| GeneOntologyBiologicalProcess | response to steroid hormone | NCOA3 ISL1 PTGS2 JAK2 NCOR1 KMT2D YAP1 TP63 NR0B1 CNOT2 FKBP4 EP300 | 2.32e-05 | 381 | 150 | 12 | GO:0048545 |
| GeneOntologyBiologicalProcess | regulation of protein localization to nucleus | 4.50e-05 | 176 | 150 | 8 | GO:1900180 | |
| GeneOntologyBiologicalProcess | estrogen receptor signaling pathway | 5.87e-05 | 57 | 150 | 5 | GO:0030520 | |
| GeneOntologyBiologicalProcess | sensory system development | EPHB2 RPGRIP1 CACNA1F CACNA1S XRN2 CELF4 FOXP2 PDE6B APC ISL1 NF1 BCAR3 NIPBL | 6.36e-05 | 491 | 150 | 13 | GO:0048880 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ZNF717 NCOA3 NCOA6 TCF12 RBMXL1 MKRN2 ASH1L MAML1 ACTN4 ISL1 BCL9 DICER1 ZNF462 JAK2 KMT2D YAP1 TP63 RBMX MAML2 MED23 NIPBL EP300 TP53BP1 NPAS2 | 6.56e-05 | 1390 | 150 | 24 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of intracellular signal transduction | EPHB2 UBQLN1 MKRN2 DUSP7 ASH1L APC ISL1 PTGS2 NCOR1 TAOK3 NF1 TP63 ARHGAP44 NR0B1 SEMA6A CNOT2 SCAI | 6.89e-05 | 795 | 150 | 17 | GO:1902532 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB2 CACNA1F MNX1 TRPC5 ADGRB3 APC ISL1 DCC DICER1 TAOK3 PLPPR4 FEZF1 ARHGAP44 KIAA1755 AFDN SEMA6A EP300 | 7.67e-05 | 802 | 150 | 17 | GO:0048812 |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | NCOA3 APC ACTN4 ISL1 JAK2 NCOR1 KMT2D TP63 RXFP2 NR0B1 SIK2 BCAR3 MBD5 CNOT2 FKBP4 EP300 | 8.17e-05 | 727 | 150 | 16 | GO:0032870 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB2 CACNA1F MNX1 TRPC5 ADGRB3 APC ISL1 DCC DICER1 TAOK3 PLPPR4 FEZF1 ARHGAP44 KIAA1755 AFDN SEMA6A EP300 | 9.90e-05 | 819 | 150 | 17 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB2 CACNA1F MNX1 TRPC5 ADGRB3 APC ISL1 DCC DICER1 TAOK3 PLPPR4 FEZF1 ARHGAP44 KIAA1755 AFDN SEMA6A EP300 | 1.10e-04 | 826 | 150 | 17 | GO:0048858 |
| GeneOntologyBiologicalProcess | embryo development | EPHB2 NCOA3 NCOA6 CELF4 FOXP2 MYO6 MNX1 ISL1 SCEL XRCC4 DICER1 NCOR1 KMT2D NF1 YAP1 TP63 KIAA1217 NR0B1 NIPBL CNOT2 EP300 PRRC2B PHLDB2 TP53BP2 | 1.10e-04 | 1437 | 150 | 24 | GO:0009790 |
| GeneOntologyBiologicalProcess | negative regulation of MAPK cascade | 1.14e-04 | 201 | 150 | 8 | GO:0043409 | |
| GeneOntologyBiologicalProcess | regulation of protein localization | EPHB2 TPR NCOA6 POLR1A IQSEC2 KIAA0586 RALGAPB APC ISL1 PTGS2 JAK2 NF1 SLC12A2 CCT5 YAP1 CEP250 TRIM17 ARHGAP44 AFDN EP300 | 1.22e-04 | 1087 | 150 | 20 | GO:0032880 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | NCOA3 NCOA6 CELF4 MNX1 ISL1 SCEL XRCC4 DICER1 NCOR1 KMT2D NF1 YAP1 KIAA1217 NIPBL CNOT2 EP300 PRRC2B TP53BP2 | 1.45e-04 | 929 | 150 | 18 | GO:0009792 |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB2 CACNA1F MYO6 MNX1 TRPC5 ADGRB3 APC ISL1 DCC DICER1 JAK2 TAOK3 NF1 PLPPR4 FEZF1 ARHGAP44 KIAA1755 TRPV4 AFDN SEMA6A FKBP4 EP300 | 1.54e-04 | 1285 | 150 | 22 | GO:0031175 |
| GeneOntologyBiologicalProcess | negative regulation of intracellular estrogen receptor signaling pathway | 1.61e-04 | 15 | 150 | 3 | GO:0033147 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to nucleus | 1.87e-04 | 114 | 150 | 6 | GO:1900182 | |
| GeneOntologyBiologicalProcess | eye development | EPHB2 RPGRIP1 CACNA1F CACNA1S XRN2 CELF4 FOXP2 PDE6B APC NF1 BCAR3 NIPBL | 2.09e-04 | 480 | 150 | 12 | GO:0001654 |
| GeneOntologyBiologicalProcess | visual system development | EPHB2 RPGRIP1 CACNA1F CACNA1S XRN2 CELF4 FOXP2 PDE6B APC NF1 BCAR3 NIPBL | 2.21e-04 | 483 | 150 | 12 | GO:0150063 |
| GeneOntologyBiologicalProcess | organelle assembly | EPHB2 TPR RPGRIP1 TCTN3 MYH7 UBQLN1 RC3H1 KIAA0586 DICER1 HPS3 LMOD3 NCOR1 YAP1 CEP250 DNAH17 CFAP58 DNAH5 DNAH8 CNOT2 EP300 | 2.25e-04 | 1138 | 150 | 20 | GO:0070925 |
| GeneOntologyBiologicalProcess | muscle tissue development | CACNA1S MYH7 FOXP2 MAML1 APC ISL1 BCL9 DICER1 LMOD3 NF1 XIRP2 YAP1 EP300 | 2.26e-04 | 558 | 150 | 13 | GO:0060537 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | TPR FOXP2 MNX1 DNAJB4 ISL1 DICER1 MYEF2 NCOR1 MTA3 UBE2I FEZF1 YAP1 TP63 NR0B1 TRPV4 NIPBL CNOT2 EP300 CBX2 | 2.35e-04 | 1053 | 150 | 19 | GO:0000122 |
| GeneOntologyBiologicalProcess | microtubule-based process | TPR DNAH3 XRN2 ASH1L APC DICER1 DNAH14 NCOR1 CEP250 DNAH17 NAV3 AP3M2 CFAP58 TRPV4 BSN DNAH5 DNAH8 FKBP4 PHLDB2 | 2.49e-04 | 1058 | 150 | 19 | GO:0007017 |
| GeneOntologyBiologicalProcess | response to heat | 2.59e-04 | 121 | 150 | 6 | GO:0009408 | |
| GeneOntologyBiologicalProcess | cell junction organization | EPHB2 LGMN CACNA1S MYO6 IQSEC2 ADGRB3 APC ACTN4 NF1 PLPPR4 XIRP2 RBMX ARHGAP44 TRPV4 AFDN BSN TNS1 PHLDB2 | 2.59e-04 | 974 | 150 | 18 | GO:0034330 |
| GeneOntologyBiologicalProcess | chromatin organization | TPR NCOA3 EP400 ASH1L DICER1 PHC1 NSD3 ZNF462 JAK2 NCOR1 KMT2D MTA3 TP63 NIPBL EP300 TP53BP1 CBX2 | 2.87e-04 | 896 | 150 | 17 | GO:0006325 |
| GeneOntologyBiologicalProcess | sensory organ development | EPHB2 RPGRIP1 CACNA1F CACNA1S XRN2 CELF4 FOXP2 PDE6B MYO6 APC DICER1 NF1 PLPPR4 BCAR3 NIPBL | 2.88e-04 | 730 | 150 | 15 | GO:0007423 |
| GeneOntologyBiologicalProcess | camera-type eye development | EPHB2 RPGRIP1 CACNA1F CACNA1S XRN2 CELF4 FOXP2 PDE6B APC NF1 BCAR3 | 2.93e-04 | 426 | 150 | 11 | GO:0043010 |
| GeneOntologyBiologicalProcess | positive regulation of growth hormone receptor signaling pathway | 3.12e-04 | 4 | 150 | 2 | GO:0060399 | |
| GeneOntologyBiologicalProcess | regulation of protein import into nucleus | 3.13e-04 | 81 | 150 | 5 | GO:0042306 | |
| GeneOntologyBiologicalProcess | cellular response to heat | 3.13e-04 | 81 | 150 | 5 | GO:0034605 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | EPHB2 RPGRIP1 NCOA3 MYH7 FOXP2 MYO6 ASH1L APC ISL1 DICER1 NF1 SLC12A2 XIRP2 YAP1 TP63 TRPV4 AFDN SEMA6A BCAR3 NIPBL EP300 | 3.49e-04 | 1269 | 150 | 21 | GO:0009887 |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 3.50e-04 | 237 | 150 | 8 | GO:0019827 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | TPR NCOA3 EP400 ASH1L DICER1 PHC1 NSD3 ZNF462 JAK2 NCOR1 KMT2D MTA3 TP63 MED23 NIPBL EP300 TP53BP1 CBX2 | 3.52e-04 | 999 | 150 | 18 | GO:0071824 |
| GeneOntologyBiologicalProcess | muscle organ development | CACNA1S MYH7 TCF12 FOXP2 MNX1 ISL1 BCL9 LMOD3 NF1 XIRP2 EP300 | 3.56e-04 | 436 | 150 | 11 | GO:0007517 |
| GeneOntologyBiologicalProcess | neuron development | EPHB2 RPGRIP1 CACNA1F MYO6 MNX1 TRPC5 ADGRB3 APC ISL1 DCC DICER1 JAK2 TAOK3 NF1 PLPPR4 FEZF1 ARHGAP44 KIAA1755 TRPV4 AFDN SEMA6A FKBP4 EP300 | 3.71e-04 | 1463 | 150 | 23 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB2 CACNA1F MNX1 TRPC5 ADGRB3 APC ISL1 DCC PLPPR4 FEZF1 ARHGAP44 KIAA1755 AFDN SEMA6A EP300 | 3.73e-04 | 748 | 150 | 15 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 type immune response | 3.76e-04 | 47 | 150 | 4 | GO:2000316 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 4.02e-04 | 242 | 150 | 8 | GO:0098727 | |
| GeneOntologyBiologicalProcess | skin development | 4.12e-04 | 373 | 150 | 10 | GO:0043588 | |
| GeneOntologyBiologicalProcess | central nervous system development | EPHB2 NCOA6 XRN2 FOXP2 MNX1 ISL1 DCC XRCC4 DICER1 NCOR1 NF1 FEZF1 NR0B1 AFDN DNAH5 MYRF ANAPC7 NIPBL TP53BP2 NPAS2 | 4.32e-04 | 1197 | 150 | 20 | GO:0007417 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | EPHB2 LGMN CELF4 SYN3 MYO6 IQSEC2 DCC PTGS2 JAK2 NF1 SLC12A2 UBE2I PLPPR4 ARHGAP44 HRH1 AFDN BSN | 4.45e-04 | 931 | 150 | 17 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | EPHB2 LGMN CELF4 SYN3 MYO6 IQSEC2 DCC PTGS2 JAK2 NF1 SLC12A2 UBE2I PLPPR4 ARHGAP44 HRH1 AFDN BSN | 4.45e-04 | 931 | 150 | 17 | GO:0007268 |
| GeneOntologyBiologicalProcess | multicellular organism growth | 4.86e-04 | 249 | 150 | 8 | GO:0035264 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | NCOA3 CACNA1S ISL1 PTGS2 JAK2 NCOR1 KMT2D TP63 NR0B1 HRH1 CNOT2 FKBP4 EP300 | 4.88e-04 | 605 | 150 | 13 | GO:0071407 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | EPHB2 LGMN CELF4 SYN3 MYO6 IQSEC2 DCC PTGS2 JAK2 NF1 SLC12A2 UBE2I PLPPR4 ARHGAP44 HRH1 AFDN BSN | 4.90e-04 | 939 | 150 | 17 | GO:0099537 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | TPR FOXP2 MNX1 DNAJB4 ISL1 DICER1 MYEF2 PHC1 NSD3 NCOR1 MTA3 UBE2I FEZF1 YAP1 TP63 NR0B1 TRPV4 NIPBL CNOT2 EP300 SCAI CBX2 | 5.02e-04 | 1399 | 150 | 22 | GO:0045892 |
| GeneOntologyBiologicalProcess | regulation of cellular localization | EPHB2 TPR NCOA6 POLR1A IQSEC2 KIAA0586 RALGAPB APC ISL1 PTGS2 JAK2 NF1 SLC12A2 CCT5 YAP1 CEP250 TRIM17 ARHGAP44 AFDN EP300 | 5.06e-04 | 1212 | 150 | 20 | GO:0060341 |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | EPHB2 TPR TRPC5 APC ISL1 DCC XRCC4 LMOD3 YAP1 ARHGAP44 NAV3 TRPV4 FKBP4 EP300 PHLDB2 VAT1 | 5.67e-04 | 864 | 150 | 16 | GO:0051129 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | TPR FOXP2 MNX1 DNAJB4 ISL1 DICER1 MYEF2 PHC1 NSD3 NCOR1 MTA3 UBE2I FEZF1 YAP1 TP63 NR0B1 TRPV4 NIPBL CNOT2 EP300 SCAI CBX2 | 5.74e-04 | 1413 | 150 | 22 | GO:1902679 |
| GeneOntologyBiologicalProcess | muscle cell development | 6.30e-04 | 259 | 150 | 8 | GO:0055001 | |
| GeneOntologyBiologicalProcess | positive regulation of protein import into nucleus | 6.41e-04 | 54 | 150 | 4 | GO:0042307 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | EPHB2 TRPC5 IQSEC2 ADGRB3 DCC XRCC4 DICER1 NF1 FEZF1 YAP1 AFDN MYRF EP300 | 6.60e-04 | 625 | 150 | 13 | GO:0051960 |
| GeneOntologyBiologicalProcess | outer dynein arm assembly | 6.82e-04 | 24 | 150 | 3 | GO:0036158 | |
| GeneOntologyBiologicalProcess | calcium ion import | 7.51e-04 | 98 | 150 | 5 | GO:0070509 | |
| GeneOntologyBiologicalProcess | synaptic signaling | EPHB2 LGMN CELF4 SYN3 MYO6 IQSEC2 DCC PTGS2 JAK2 NF1 SLC12A2 UBE2I PLPPR4 ARHGAP44 HRH1 AFDN BSN | 7.55e-04 | 976 | 150 | 17 | GO:0099536 |
| GeneOntologyBiologicalProcess | negative regulation of Rac protein signal transduction | 7.73e-04 | 6 | 150 | 2 | GO:0035021 | |
| GeneOntologyBiologicalProcess | uterus morphogenesis | 7.73e-04 | 6 | 150 | 2 | GO:0061038 | |
| GeneOntologyBiologicalProcess | molting cycle | 8.10e-04 | 150 | 150 | 6 | GO:0042303 | |
| GeneOntologyBiologicalProcess | hair cycle | 8.10e-04 | 150 | 150 | 6 | GO:0042633 | |
| GeneOntologyBiologicalProcess | axon development | EPHB2 CACNA1F MNX1 TRPC5 APC ISL1 DCC JAK2 PLPPR4 FEZF1 KIAA1755 SEMA6A EP300 | 8.45e-04 | 642 | 150 | 13 | GO:0061564 |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 8.84e-04 | 210 | 150 | 7 | GO:0060294 | |
| GeneOntologyBiologicalProcess | axonogenesis | EPHB2 CACNA1F MNX1 TRPC5 APC ISL1 DCC PLPPR4 FEZF1 KIAA1755 SEMA6A EP300 | 9.04e-04 | 566 | 150 | 12 | GO:0007409 |
| GeneOntologyBiologicalProcess | forebrain development | EPHB2 XRN2 FOXP2 ISL1 DICER1 NCOR1 NF1 FEZF1 NR0B1 AFDN DNAH5 | 9.19e-04 | 489 | 150 | 11 | GO:0030900 |
| GeneOntologyBiologicalProcess | learning | 9.34e-04 | 212 | 150 | 7 | GO:0007612 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | NCOA3 NCOA6 CELF4 MNX1 ISL1 XRCC4 DICER1 NCOR1 KMT2D NF1 YAP1 KIAA1217 NIPBL CNOT2 EP300 PRRC2B | 9.39e-04 | 906 | 150 | 16 | GO:0043009 |
| GeneOntologyBiologicalProcess | protein localization to organelle | TPR POLR1A IQSEC2 APC XRCC4 PTGS2 JAK2 NF1 NUP155 CCT5 YAP1 CEP250 CFAP58 WDR83OS NIPBL EP300 TP53BP1 DCP1A | 9.82e-04 | 1091 | 150 | 18 | GO:0033365 |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 1.01e-03 | 215 | 150 | 7 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 1.01e-03 | 215 | 150 | 7 | GO:0001539 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | 1.04e-03 | 421 | 150 | 10 | GO:0048638 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 1.08e-03 | 7 | 150 | 2 | GO:0007221 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to centrosome | 1.08e-03 | 7 | 150 | 2 | GO:1904781 | |
| GeneOntologyBiologicalProcess | regulation of growth hormone receptor signaling pathway | 1.08e-03 | 7 | 150 | 2 | GO:0060398 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB2 CACNA1F MNX1 TRPC5 ADGRB3 APC ISL1 DCC DICER1 TAOK3 PLPPR4 FEZF1 YAP1 ARHGAP44 KIAA1755 AFDN SEMA6A EP300 ZMYM4 | 1.08e-03 | 1194 | 150 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | cellular response to lipid | EPHB2 NCOA3 ISL1 PHC1 JAK2 NCOR1 KMT2D SLC12A2 YAP1 TP63 NR0B1 CNOT2 FKBP4 EP300 | 1.14e-03 | 748 | 150 | 14 | GO:0071396 |
| GeneOntologyBiologicalProcess | response to radiation | CACNA1F PDE6B XRCC4 NF1 YAP1 CEP250 HRH1 NIPBL EP300 TP53BP1 TP53BP2 | 1.15e-03 | 503 | 150 | 11 | GO:0009314 |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 1.16e-03 | 108 | 150 | 5 | GO:0035019 | |
| GeneOntologyBiologicalProcess | T-helper 17 type immune response | 1.22e-03 | 64 | 150 | 4 | GO:0072538 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.29e-03 | 65 | 150 | 4 | GO:0000288 | |
| GeneOntologyBiologicalProcess | response to X-ray | 1.33e-03 | 30 | 150 | 3 | GO:0010165 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 1.36e-03 | 362 | 150 | 9 | GO:0034504 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 1.37e-03 | 166 | 150 | 6 | GO:0098773 | |
| GeneOntologyCellularComponent | dynein complex | 2.69e-06 | 54 | 153 | 6 | GO:0030286 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 3.10e-05 | 25 | 153 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TPR NCOA3 NCOA6 TCF12 POLR1A EP400 RBMXL1 MED13L XRCC4 BCL9 PHC1 NCOR1 KMT2D NUP155 MTA3 UBE2I YAP1 RBMX ASCC3 MED23 ANAPC7 NIPBL CBX2 NPAS2 | 6.35e-05 | 1377 | 153 | 24 | GO:0140513 |
| GeneOntologyCellularComponent | outer dynein arm | 8.06e-05 | 12 | 153 | 3 | GO:0036157 | |
| GeneOntologyCellularComponent | ribbon synapse | 8.46e-05 | 32 | 153 | 4 | GO:0097470 | |
| GeneOntologyCellularComponent | supraspliceosomal complex | 3.16e-04 | 4 | 153 | 2 | GO:0044530 | |
| GeneOntologyCellularComponent | transcription regulator complex | NCOA3 NCOA6 TCF12 ISL1 BCL9 NCOR1 MTA3 YAP1 ASCC3 MED23 EP300 DCP1A NPAS2 | 4.52e-04 | 596 | 153 | 13 | GO:0005667 |
| GeneOntologyCellularComponent | postsynapse | EPHB2 CACNA1S CELF4 SYN3 MYO6 IQSEC2 ADGRB3 APC ACTN4 DCC DICER1 JAK2 UBE2I PLPPR4 RBMX ARHGAP44 AFDN BSN | 4.78e-04 | 1018 | 153 | 18 | GO:0098794 |
| GeneOntologyCellularComponent | neuron to neuron synapse | EPHB2 SYN3 MYO6 IQSEC2 ADGRB3 DCC DICER1 PLPPR4 RBMX ARHGAP44 AFDN BSN | 4.81e-04 | 523 | 153 | 12 | GO:0098984 |
| GeneOntologyCellularComponent | postsynaptic density | SYN3 MYO6 IQSEC2 ADGRB3 DCC DICER1 PLPPR4 RBMX ARHGAP44 AFDN BSN | 5.00e-04 | 451 | 153 | 11 | GO:0014069 |
| GeneOntologyCellularComponent | DNA repair complex | 6.11e-04 | 23 | 153 | 3 | GO:1990391 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | UBQLN1 POLR1A EP400 APC XRCC4 DICER1 HPS3 PHC1 CCT5 UBE3D FBXO42 WDR83OS MED23 ANAPC7 CNOT2 EP300 CBX2 | 7.80e-04 | 972 | 153 | 17 | GO:0140535 |
| GeneOntologyCellularComponent | cochlear hair cell ribbon synapse | 7.83e-04 | 6 | 153 | 2 | GO:0098683 | |
| GeneOntologyCellularComponent | asymmetric synapse | SYN3 MYO6 IQSEC2 ADGRB3 DCC DICER1 PLPPR4 RBMX ARHGAP44 AFDN BSN | 7.94e-04 | 477 | 153 | 11 | GO:0032279 |
| GeneOntologyCellularComponent | presynapse | EPHB2 SYN3 MYO6 VPS45 TRPC5 IQSEC2 APC PHAF1 NF1 SEPTIN3 UBE2I ARHGAP44 AP3M2 AFDN EGFLAM BSN | 7.99e-04 | 886 | 153 | 16 | GO:0098793 |
| GeneOntologyCellularComponent | glutamatergic synapse | EPHB2 SYN3 MYO6 IQSEC2 ADGRB3 APC DICER1 JAK2 NF1 UBE2I PLPPR4 RBMX ARHGAP44 AP3M2 BSN | 9.90e-04 | 817 | 153 | 15 | GO:0098978 |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 9.94e-04 | 155 | 153 | 6 | GO:0098685 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.21e-03 | 161 | 153 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | postsynaptic specialization | SYN3 MYO6 IQSEC2 ADGRB3 DCC DICER1 PLPPR4 RBMX ARHGAP44 AFDN BSN | 1.22e-03 | 503 | 153 | 11 | GO:0099572 |
| GeneOntologyCellularComponent | cytoplasmic region | 1.37e-03 | 360 | 153 | 9 | GO:0099568 | |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB2 CACNA1F CACNA1S MYO6 TRPC5 APC DICER1 PHAF1 NF1 SLC12A2 UBE2I TP63 SEPTIN14 ARHGAP44 HRH1 AFDN BSN FKBP4 DCP1A | 1.63e-03 | 1228 | 153 | 19 | GO:0036477 |
| GeneOntologyCellularComponent | cell cortex | 1.68e-03 | 371 | 153 | 9 | GO:0005938 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.89e-03 | 238 | 153 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.03e-03 | 73 | 153 | 4 | GO:0034704 | |
| HumanPheno | Pilomatrixoma | 1.96e-06 | 9 | 59 | 4 | HP:0030434 | |
| HumanPheno | Abnormality of the diaphragm | 2.86e-05 | 141 | 59 | 9 | HP:0000775 | |
| HumanPheno | Skin appendage neoplasm | 4.40e-05 | 18 | 59 | 4 | HP:0012842 | |
| HumanPheno | Functional abnormality of male internal genitalia | RPGRIP1 TCTN3 TCF12 POLR1A PDE6B ASH1L DNAJB4 TNRC6B ISL1 MED13L DCC XRCC4 DICER1 ZNF462 KMT2D NF1 FEZF1 TP63 RBMX DNAH17 NR0B1 CFAP58 MBD5 DNAH5 DNAH8 MYRF NIPBL EP300 CBX2 | 4.54e-05 | 1269 | 59 | 29 | HP:0000025 |
| HumanPheno | Abnormal internal genitalia | EPHB2 TPR RPGRIP1 TCTN3 TCF12 POLR1A PDE6B MNX1 ASH1L APC DNAJB4 TNRC6B ISL1 MED13L DCC XRCC4 DICER1 ZNF462 KMT2D MLH3 NF1 FEZF1 TP63 RBMX DNAH17 NR0B1 MBD5 MYRF ANAPC7 NIPBL EP300 CBX2 | 5.28e-05 | 1498 | 59 | 32 | HP:0000812 |
| HumanPheno | Intestinal malrotation | 6.69e-05 | 157 | 59 | 9 | HP:0002566 | |
| HumanPheno | Abnormal male reproductive system physiology | RPGRIP1 TCTN3 TCF12 POLR1A PDE6B ASH1L DNAJB4 TNRC6B ISL1 MED13L DCC XRCC4 DICER1 ZNF462 KMT2D NF1 FEZF1 TP63 RBMX DNAH17 NR0B1 CFAP58 MBD5 DNAH5 DNAH8 MYRF NIPBL EP300 CBX2 | 9.03e-05 | 1314 | 59 | 29 | HP:0012874 |
| HumanPheno | Abnormal male internal genitalia morphology | EPHB2 RPGRIP1 TCTN3 TCF12 POLR1A PDE6B ASH1L APC DNAJB4 TNRC6B ISL1 MED13L DCC XRCC4 DICER1 ZNF462 KMT2D NF1 FEZF1 TP63 RBMX DNAH17 NR0B1 MBD5 MYRF NIPBL EP300 CBX2 | 9.10e-05 | 1243 | 59 | 28 | HP:0000022 |
| HumanPheno | Bilateral choanal atresia | 1.18e-04 | 9 | 59 | 3 | HP:0004502 | |
| HumanPheno | Clavicular pseudarthrosis | 1.32e-04 | 2 | 59 | 2 | HP:0034187 | |
| MousePheno | pale kidney | 1.34e-05 | 33 | 132 | 5 | MP:0004969 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.66e-06 | 14 | 149 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.66e-06 | 14 | 149 | 4 | IPR024743 | |
| Domain | MT | 3.66e-06 | 14 | 149 | 4 | PF12777 | |
| Domain | AAA_8 | 3.66e-06 | 14 | 149 | 4 | PF12780 | |
| Domain | DHC_fam | 4.96e-06 | 15 | 149 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 4.96e-06 | 15 | 149 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.96e-06 | 15 | 149 | 4 | IPR004273 | |
| Domain | RmlC_Cupin | 6.57e-06 | 16 | 149 | 4 | IPR011051 | |
| Domain | INT_SG_DDX_CT_C | 2.71e-05 | 8 | 149 | 3 | PF15300 | |
| Domain | INT_SG_DDX_CT_C | 2.71e-05 | 8 | 149 | 3 | IPR029307 | |
| Domain | Dynein_heavy_dom-2 | 1.70e-04 | 14 | 149 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.70e-04 | 14 | 149 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.70e-04 | 14 | 149 | 3 | IPR011704 | |
| Domain | AAA_5 | 1.70e-04 | 14 | 149 | 3 | PF07728 | |
| Domain | MamL-1 | 1.89e-04 | 3 | 149 | 2 | SM01275 | |
| Domain | Neuroggenic_mastermind-like_N | 1.89e-04 | 3 | 149 | 2 | IPR019082 | |
| Domain | MamL-1 | 1.89e-04 | 3 | 149 | 2 | PF09596 | |
| Domain | Post-SET_dom | 2.58e-04 | 16 | 149 | 3 | IPR003616 | |
| Domain | PostSET | 2.58e-04 | 16 | 149 | 3 | SM00508 | |
| Domain | POST_SET | 2.58e-04 | 16 | 149 | 3 | PS50868 | |
| Domain | VDCC_L_a1su | 3.75e-04 | 4 | 149 | 2 | IPR005446 | |
| Domain | AWS | 6.22e-04 | 5 | 149 | 2 | SM00570 | |
| Domain | AWS | 6.22e-04 | 5 | 149 | 2 | PS51215 | |
| Domain | AWS_dom | 6.22e-04 | 5 | 149 | 2 | IPR006560 | |
| Domain | Nuc_rcpt_coact | 9.29e-04 | 6 | 149 | 2 | IPR009110 | |
| Domain | P-loop_NTPase | DDX19A DNAH3 MYH7 EP400 MYO6 DICER1 DNAH14 ARF5 NWD2 SEPTIN3 SEPTIN14 DDX25 NAV3 ASCC3 DNAH5 DNAH8 | 1.23e-03 | 848 | 149 | 16 | IPR027417 |
| Domain | Znf_MYM | 1.29e-03 | 7 | 149 | 2 | IPR010507 | |
| Domain | Ca_chan_IQ | 1.29e-03 | 7 | 149 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 1.29e-03 | 7 | 149 | 2 | PF08763 | |
| Domain | VDCC_a1su_IQ | 1.29e-03 | 7 | 149 | 2 | IPR014873 | |
| Domain | GPHH | 1.29e-03 | 7 | 149 | 2 | PF16905 | |
| Domain | GPHH_dom | 1.29e-03 | 7 | 149 | 2 | IPR031649 | |
| Domain | zf-FCS | 1.29e-03 | 7 | 149 | 2 | PF06467 | |
| Domain | Helicase_C | 1.67e-03 | 107 | 149 | 5 | PF00271 | |
| Domain | HELICc | 1.67e-03 | 107 | 149 | 5 | SM00490 | |
| Domain | Sec1-like | 1.72e-03 | 8 | 149 | 2 | IPR001619 | |
| Domain | DHC_N1 | 1.72e-03 | 8 | 149 | 2 | PF08385 | |
| Domain | Sec-1-like_dom2 | 1.72e-03 | 8 | 149 | 2 | IPR027482 | |
| Domain | Sec1 | 1.72e-03 | 8 | 149 | 2 | PF00995 | |
| Domain | RBM1CTR | 1.72e-03 | 8 | 149 | 2 | PF08081 | |
| Domain | RBM1CTR | 1.72e-03 | 8 | 149 | 2 | IPR012604 | |
| Domain | - | 1.72e-03 | 8 | 149 | 2 | 3.40.50.1910 | |
| Domain | Dynein_heavy_dom-1 | 1.72e-03 | 8 | 149 | 2 | IPR013594 | |
| Domain | Helicase_C | 1.74e-03 | 108 | 149 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 1.81e-03 | 109 | 149 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.81e-03 | 109 | 149 | 5 | PS51192 | |
| Domain | DEXDc | 1.81e-03 | 109 | 149 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.89e-03 | 110 | 149 | 5 | IPR014001 | |
| Pathway | REACTOME_ADIPOGENESIS | 4.19e-05 | 110 | 120 | 7 | M48259 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 4.74e-05 | 47 | 120 | 5 | M27395 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 4.86e-05 | 77 | 120 | 6 | M27226 | |
| Pathway | PID_HES_HEY_PATHWAY | 5.25e-05 | 48 | 120 | 5 | M288 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 6.56e-05 | 118 | 120 | 7 | M27316 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 6.91e-05 | 10 | 120 | 3 | MM15535 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 7.53e-05 | 27 | 120 | 4 | M47755 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 7.94e-05 | 84 | 120 | 6 | M1008 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 7.94e-05 | 84 | 120 | 6 | MM14929 | |
| Pathway | REACTOME_SUMOYLATION | 9.72e-05 | 169 | 120 | 8 | MM14919 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.25e-04 | 12 | 120 | 3 | M27159 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.31e-04 | 58 | 120 | 5 | MM15149 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.67e-04 | 61 | 120 | 5 | M39540 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 2.04e-04 | 14 | 120 | 3 | M27808 | |
| Pathway | REACTOME_SUMOYLATION | 2.10e-04 | 189 | 120 | 8 | M27214 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 2.26e-04 | 65 | 120 | 5 | MM15147 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 3.11e-04 | 16 | 120 | 3 | M27121 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS | 3.11e-04 | 16 | 120 | 3 | M27403 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 3.42e-04 | 71 | 120 | 5 | M27394 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 3.60e-04 | 40 | 120 | 4 | MM15000 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 4.47e-04 | 18 | 120 | 3 | MM14775 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 4.77e-04 | 43 | 120 | 4 | M47669 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 5.21e-04 | 44 | 120 | 4 | M27295 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 5.68e-04 | 45 | 120 | 4 | M47670 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 6.17e-04 | 20 | 120 | 3 | M27881 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 6.65e-04 | 82 | 120 | 5 | MM15922 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 7.28e-04 | 48 | 120 | 4 | M611 | |
| Pathway | REACTOME_HEME_SIGNALING | 7.87e-04 | 49 | 120 | 4 | M41832 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 8.23e-04 | 22 | 120 | 3 | MM1370 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | TPR TCF12 POLR1A MAML1 TNRC6B PHC1 KMT2D NUP155 MTA3 UBE2I YAP1 TP63 NR0B1 MAML2 ZNF844 CNOT2 EP300 TP53BP2 CBX2 | 9.92e-04 | 1022 | 120 | 19 | MM15436 |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.05e-03 | 6 | 120 | 2 | M47762 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 1.07e-03 | 91 | 120 | 5 | M39700 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.12e-03 | 92 | 120 | 5 | MM14951 | |
| Pubmed | TPR NCOA3 ZSCAN12 FOXP2 IQSEC2 ADGRB3 APC TNRC6B BCL9 ITIH4 MYEF2 ARF5 ZNF462 NCOR1 NF1 SEPTIN3 PLPPR4 FAM120C KIAA1217 ARHGAP44 AFDN BSN TNS1 NIPBL TP53BP1 PRRC2B PHLDB2 TP53BP2 | 3.61e-15 | 963 | 156 | 28 | 28671696 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | TPR NCOA3 DDX19A NCOA6 RBMS2 RC3H1 MAML1 TNRC6B BCL9 MYEF2 NCOR1 KMT2D NUP155 RBMX CNOT2 FKBP4 EP300 PRRC2B | 3.13e-12 | 457 | 156 | 18 | 32344865 |
| Pubmed | NCOA3 NCOA6 XRN2 TCF12 UBQLN1 EP400 MAML1 ACTN4 MED13L BCL9 NCOR1 TAOK3 KMT2D MTA3 UBE2I CCT5 RBMX SEPTIN14 MED23 ANAPC7 NIPBL FKBP4 EP300 ZMYM4 TP53BP1 PRRC2B | 4.53e-12 | 1103 | 156 | 26 | 34189442 | |
| Pubmed | NCOA3 NCOA6 XRN2 TCF12 EP400 FOXP2 MYO6 MNX1 RC3H1 MAML1 TNRC6B BCL9 ZNF462 NCOR1 KMT2D MTA3 UBE2I CCT5 YAP1 NIPBL CNOT2 FKBP4 EP300 ZMYM4 TP53BP1 PRRC2B DCP1A CBX2 | 4.71e-11 | 1429 | 156 | 28 | 35140242 | |
| Pubmed | TPR NCOA6 EP400 TNRC6B NSD3 NCOR1 KMT2D CCT5 YAP1 AFDN ASCC3 MED23 EP300 ZMYM4 TP53BP1 PRRC2B TP53BP2 DCP1A | 6.35e-11 | 549 | 156 | 18 | 38280479 | |
| Pubmed | 1.44e-10 | 83 | 156 | 9 | 28794006 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA3 NCOA6 EP400 FOXP2 MNX1 MAML1 BCL9 ZNF462 NCOR1 KMT2D NIPBL EP300 ZMYM4 PRRC2B | 7.68e-10 | 351 | 156 | 14 | 38297188 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | CACNA1S NCOA6 FMO1 UBQLN1 EP400 BCL9 NCOR1 SLC12A2 NUP155 XIRP2 YAP1 TP63 MAML2 BSN TP53BP2 | 1.17e-09 | 430 | 156 | 15 | 35044719 |
| Pubmed | TPR SYN3 VPS45 IQSEC2 ACBD5 ADGRB3 APC TNRC6B ACTN4 MYEF2 ARF5 HSPA12A NF1 SEPTIN3 PLPPR4 CCT5 FAM120C KIAA1217 NAV3 AFDN BSN CNOT2 TP53BP1 | 1.75e-09 | 1139 | 156 | 23 | 36417873 | |
| Pubmed | NCOA3 NCOA6 EP400 MAML1 MED13L BCL9 NCOR1 KMT2D MTA3 YAP1 NIPBL PRRC2B | 3.60e-09 | 268 | 156 | 12 | 33640491 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 4.77e-09 | 167 | 156 | 10 | 20362541 | |
| Pubmed | Identification of cancer/testis-antigen genes by massively parallel signature sequencing. | 4.93e-09 | 15 | 156 | 5 | 15905330 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | TPR NCOA3 XRN2 MYEF2 ZNF462 NCOR1 KMT2D MED23 FKBP4 EP300 ZMYM4 | 5.27e-09 | 220 | 156 | 11 | 35785414 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR NCOA3 NCOA6 XRN2 EP400 RALGAPB BCL9 NCOR1 KMT2D NF1 YAP1 RBMX AFDN NIPBL ZMYM4 TP53BP1 PHLDB2 DCP1A | 1.42e-08 | 774 | 156 | 18 | 15302935 |
| Pubmed | NCOA6 ZSCAN12 EP400 ADGRB3 MAML1 DICER1 MYEF2 NUP155 MTA3 PLPPR4 CCT5 MAML2 BSN MED23 ZMYM4 | 1.87e-08 | 529 | 156 | 15 | 14621295 | |
| Pubmed | SYN3 MYO6 VPS45 IQSEC2 APC ACTN4 PTGS2 MYEF2 ARF5 HSPA12A NWD2 NF1 PLPPR4 CCT5 FAM120C KIAA1217 RBMX ARHGAP44 AFDN BSN TNS1 PRRC2B TP53BP2 SCAI | 2.69e-08 | 1431 | 156 | 24 | 37142655 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | RPGRIP1 NCOA3 TCTN3 XRN2 VPS45 IQSEC2 MAML1 DNAJB4 ACTN4 XRCC4 DICER1 NF1 UBE3D YAP1 ARHGAP44 AFDN ANAPC7 CNOT2 TP53BP1 PRRC2B PHLDB2 TP53BP2 DCP1A | 2.75e-08 | 1321 | 156 | 23 | 27173435 |
| Pubmed | TPR NCOA3 XRN2 POLR1A EP400 DNAJB4 MED13L XRCC4 NSD3 NCOR1 NUP155 MTA3 UBE2I CCT5 YAP1 MED23 ANAPC7 NIPBL FKBP4 EP300 | 3.26e-08 | 1014 | 156 | 20 | 32416067 | |
| Pubmed | 3.27e-08 | 21 | 156 | 5 | 19596656 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | ADGRB3 APC TNRC6B MYEF2 NCOR1 NWD2 NF1 NUP155 CCT5 FAM120C NAV3 TP53BP1 PRRC2B DCP1A | 3.54e-08 | 475 | 156 | 14 | 31040226 |
| Pubmed | TPR XRN2 POLR1A ACTN4 DICER1 MYEF2 NF1 NUP155 CCT5 RBMX AFDN ASCC3 NIPBL FKBP4 TP53BP1 PRRC2B | 4.65e-08 | 653 | 156 | 16 | 22586326 | |
| Pubmed | TPR NCOA3 APC TNRC6B PHC1 ZNF462 NCOR1 KMT2D NR0B1 ASCC3 ZMYM4 TP53BP2 DCP1A | 5.98e-08 | 418 | 156 | 13 | 34709266 | |
| Pubmed | UBQLN1 POLR1A EP400 VPS45 RALGAPB ACBD5 MAML1 APC TNRC6B DICER1 MYEF2 NSD3 SEPTIN3 SLC12A2 MTA3 CCT5 FAM120C AFDN ASCC3 MED23 ANAPC7 NIPBL CNOT2 ZMYM4 | 6.25e-08 | 1497 | 156 | 24 | 31527615 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPR DDX19A XRN2 POLR1A EP400 ACTN4 DICER1 MYEF2 NF1 SLC12A2 NUP155 CCT5 RBMX AFDN ASCC3 ANAPC7 NIPBL FKBP4 PHLDB2 | 1.89e-07 | 1024 | 156 | 19 | 24711643 |
| Pubmed | SCFD2 NCOA3 NCOA6 MYO6 MAML1 MUC16 BCL9 MYEF2 NCOR1 KMT2D NF1 BSN NIPBL EP300 PRRC2B | 2.12e-07 | 638 | 156 | 15 | 31182584 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 3.41e-07 | 146 | 156 | 8 | 23892456 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TPR MYH7 TCF12 EP400 FOXP2 MAML1 ISL1 MYEF2 NCOR1 KMT2D RBMX FBXO42 ANAPC7 EP300 ZMYM4 TP53BP1 DCP1A | 3.48e-07 | 857 | 156 | 17 | 25609649 |
| Pubmed | MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis. | 3.53e-07 | 4 | 156 | 3 | 32482852 | |
| Pubmed | 3.76e-07 | 14 | 156 | 4 | 9373155 | ||
| Pubmed | 4.78e-07 | 209 | 156 | 9 | 36779422 | ||
| Pubmed | TCF12 EP400 MYO6 VPS45 ACBD5 MAML1 APC MUC16 TNRC6B ARF5 NCOR1 SLC12A2 NUP155 CCT5 AFDN PRRC2B | 4.81e-07 | 777 | 156 | 16 | 35844135 | |
| Pubmed | TPR NCOA3 XRN2 APC NCOR1 YAP1 RBMX AFDN BCAR3 NIPBL FKBP4 TP53BP1 PHLDB2 | 4.94e-07 | 503 | 156 | 13 | 16964243 | |
| Pubmed | 5.94e-07 | 157 | 156 | 8 | 30186101 | ||
| Pubmed | TCF12 EP400 FOXP2 ASH1L TNRC6B SCEL DICER1 ITIH4 MYEF2 NSD3 TTC7A MLH3 MTA3 FAM120C ASCC3 ANAPC7 EP300 PRRC2B PHLDB2 | 6.93e-07 | 1116 | 156 | 19 | 31753913 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | TCF12 EP400 ACTN4 NCOR1 NUP155 UBE2I CCT5 ASCC3 MED23 ZMYM4 PRRC2B | 7.07e-07 | 357 | 156 | 11 | 37059091 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | EPHB2 MYH7 CT45A1 POLR1A DICER1 ARF5 JAK2 TAOK3 NF1 MTA3 CT45A3 SIK2 BCAR3 TNS1 ANAPC7 EP300 SCAI | 7.95e-07 | 910 | 156 | 17 | 36736316 |
| Pubmed | 8.85e-07 | 225 | 156 | 9 | 12168954 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RNF130 POLR1A MYO6 VPS45 RALGAPB ASH1L TNRC6B DNAH14 HPS3 ZNF462 JAK2 PTPN4 MTA3 FAM120C KIAA1217 FBXO42 ARHGAP44 SEMA6A MBD5 EP300 ZMYM4 NPAS2 | 9.24e-07 | 1489 | 156 | 22 | 28611215 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | TCF12 RBMXL1 TNRC6B MED13L DICER1 ZNF462 NCOR1 PTPN4 KIAA1217 MBD5 NIPBL CNOT2 FKBP4 | 1.00e-06 | 536 | 156 | 13 | 15840001 |
| Pubmed | TCF12 RBMXL1 TNRC6B MED13L DICER1 ZNF462 NCOR1 PTPN4 KIAA1217 MBD5 NIPBL CNOT2 FKBP4 | 1.05e-06 | 538 | 156 | 13 | 10512203 | |
| Pubmed | Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. | 1.08e-06 | 170 | 156 | 8 | 19064572 | |
| Pubmed | RALGAPB ACBD5 ACTN4 NSD3 NCOR1 PTPN4 HSPA12A KMT2D SLC12A2 NUP155 CCT5 TNS1 FKBP4 PRRC2B TP53BP2 DCP1A CBX2 VAT1 | 1.24e-06 | 1049 | 156 | 18 | 27880917 | |
| Pubmed | XRN2 UBQLN1 MYO6 VPS45 IQSEC2 ASH1L ADGRB3 APC ACTN4 MED13L SEPTIN3 MTA3 UBE2I NAV3 AFDN NIPBL CNOT2 EP300 ZMYM4 SCAI | 1.38e-06 | 1285 | 156 | 20 | 35914814 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TPR DDX19A XRN2 POLR1A MYO6 KIAA0586 ACTN4 DICER1 NF1 NUP155 CCT5 RBMX AFDN BSN MED23 DNAH5 ANAPC7 NIPBL FKBP4 VAT1 NPAS2 | 1.74e-06 | 1425 | 156 | 21 | 30948266 |
| Pubmed | 1.78e-06 | 20 | 156 | 4 | 11877444 | ||
| Pubmed | Automated yeast two-hybrid screening for nuclear receptor-interacting proteins. | 2.47e-06 | 133 | 156 | 7 | 15604093 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TPR RNF130 DDX19A XRN2 ARF5 HSPA12A NF1 NUP155 CCT5 FAM120C RBMX ANAPC7 NIPBL | 2.49e-06 | 582 | 156 | 13 | 20467437 |
| Pubmed | NCOA6 UBQLN1 MYO6 ASH1L NCOR1 KMT2D NUP155 UBE2I CEP250 AFDN ASCC3 TP53BP2 DCP1A | 2.94e-06 | 591 | 156 | 13 | 15231748 | |
| Pubmed | RBMS2 IQSEC2 DUSP7 ASH1L APC CLHC1 MYEF2 PHC1 NSD3 NCOR1 MAML2 MBD5 PRRC2B CBX2 | 3.02e-06 | 689 | 156 | 14 | 36543142 | |
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 37166352 | ||
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 9256245 | ||
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 31178125 | ||
| Pubmed | 3.23e-06 | 23 | 156 | 4 | 9225980 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | NCOA6 EP400 MYEF2 NCOR1 KMT2D FAM120C YAP1 CNOT2 TP53BP1 DCP1A | 3.56e-06 | 341 | 156 | 10 | 32971831 |
| Pubmed | NCOA3 ZSCAN12 TCF12 FOXP2 MKRN2 ASH1L PHC1 ZNF462 NCOR1 MTA3 NR0B1 ZNF844 CNOT2 CBX2 NPAS2 | 3.96e-06 | 808 | 156 | 15 | 20412781 | |
| Pubmed | 4.88e-06 | 8 | 156 | 3 | 10823961 | ||
| Pubmed | Nolz1 expression is required in dopaminergic axon guidance and striatal innervation. | 4.94e-06 | 55 | 156 | 5 | 32561725 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | XRN2 POLR1A EP400 APC DICER1 MYEF2 NF1 NUP155 ASCC3 MED23 TP53BP1 | 5.28e-06 | 440 | 156 | 11 | 34244565 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | POLR1A MYO6 RBMS2 RC3H1 APC TNRC6B DICER1 ARF5 PHAF1 CCT5 FAM120C ASCC3 ANAPC7 PRRC2B | 5.32e-06 | 724 | 156 | 14 | 36232890 |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 5.49e-06 | 150 | 156 | 7 | 28242625 | |
| Pubmed | 5.62e-06 | 282 | 156 | 9 | 23667531 | ||
| Pubmed | 5.99e-06 | 152 | 156 | 7 | 38360978 | ||
| Pubmed | 7.39e-06 | 103 | 156 | 6 | 10574462 | ||
| Pubmed | TCTN3 DUSP7 KIAA0586 ASH1L DNAJB4 BCL9 DNAH14 MYEF2 PHC1 ARF5 NF1 BCAR3 ASCC3 NIPBL EP300 PRRC2B DCP1A CBX2 | 9.47e-06 | 1215 | 156 | 18 | 15146197 | |
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 1.02e-05 | 109 | 156 | 6 | 33554859 | |
| Pubmed | HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia. | 1.04e-05 | 10 | 156 | 3 | 23746844 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPR DDX19A XRN2 POLR1A EP400 MYO6 ACTN4 MYEF2 NF1 NUP155 CCT5 RBMX AFDN ASCC3 NIPBL TP53BP1 PHLDB2 TP53BP2 DCP1A | 1.12e-05 | 1353 | 156 | 19 | 29467282 |
| Pubmed | 1.13e-05 | 65 | 156 | 5 | 22496869 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | CT45A1 CELF4 MYO6 MKRN2 RALGAPB ACBD5 CT45A2 ACTN4 CT45A9 NF1 MTA3 CT45A3 RBMX CEP250 TRIM17 DNAH17 MED23 PRRC2B | 1.27e-05 | 1242 | 156 | 18 | 30973865 |
| Pubmed | 1.32e-05 | 114 | 156 | 6 | 21150319 | ||
| Pubmed | 1.34e-05 | 486 | 156 | 11 | 20936779 | ||
| Pubmed | TPR NCOA6 UBQLN1 MYO6 APC TNRC6B ACTN4 MED13L NCOR1 CCT5 YAP1 RBMX ASCC3 CNOT2 FKBP4 PHLDB2 TP53BP2 DCP1A | 1.34e-05 | 1247 | 156 | 18 | 27684187 | |
| Pubmed | Control of oligodendrocyte generation and proliferation by Shp2 protein tyrosine phosphatase. | 1.42e-05 | 11 | 156 | 3 | 20648636 | |
| Pubmed | 1.42e-05 | 11 | 156 | 3 | 28673820 | ||
| Pubmed | 1.44e-05 | 33 | 156 | 4 | 20301390 | ||
| Pubmed | 1.46e-05 | 116 | 156 | 6 | 21282530 | ||
| Pubmed | A global genomic transcriptional code associated with CNS-expressed genes. | 1.47e-05 | 318 | 156 | 9 | 16919269 | |
| Pubmed | RPGRIP1 NCOA3 TCF12 UBQLN1 FOXP2 MKRN2 PTGS2 TP53BP2 DCP1A NPAS2 | 1.49e-05 | 402 | 156 | 10 | 24722188 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | XRN2 EP400 MAML1 APC NCOR1 YAP1 KIAA1217 FBXO42 BSN ZMYM4 TP53BP1 PRRC2B | 1.51e-05 | 588 | 156 | 12 | 38580884 |
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 1.52e-05 | 69 | 156 | 5 | 28481362 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | NCOA6 PHC1 ZNF462 KMT2D MTA3 CCT5 FBXO42 MBD5 ZMYM4 SCAI CBX2 | 1.59e-05 | 495 | 156 | 11 | 27705803 |
| Pubmed | Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. | 1.89e-05 | 12 | 156 | 3 | 14645221 | |
| Pubmed | 1.89e-05 | 12 | 156 | 3 | 28700933 | ||
| Pubmed | MicroRNA filters Hox temporal transcription noise to confer boundary formation in the spinal cord. | 1.89e-05 | 12 | 156 | 3 | 28337978 | |
| Pubmed | MicroRNAs are essential for development and function of inner ear hair cells in vertebrates. | 1.89e-05 | 12 | 156 | 3 | 19416898 | |
| Pubmed | Afadin Signaling at the Spinal Neuroepithelium Regulates Central Canal Formation and Gait Selection. | 1.89e-05 | 12 | 156 | 3 | 32521266 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 8945508 | ||
| Pubmed | Self-promotion? Intimate connections between APC and prostaglandin H synthase-2. | 2.00e-05 | 2 | 156 | 2 | 8945503 | |
| Pubmed | DCC constrains tumour progression via its dependence receptor activity. | 2.00e-05 | 2 | 156 | 2 | 22158121 | |
| Pubmed | KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis. | 2.00e-05 | 2 | 156 | 2 | 29440247 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 33982216 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 35546636 | ||
| Pubmed | Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F. | 2.00e-05 | 2 | 156 | 2 | 18033315 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 12151354 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 12089344 | ||
| Pubmed | The protein stability and transcriptional activity of p63alpha are regulated by SUMO-1 conjugation. | 2.00e-05 | 2 | 156 | 2 | 15611636 | |
| Pubmed | Recurrent YAP1 and MAML2 Gene Rearrangements in Retiform and Composite Hemangioendothelioma. | 2.00e-05 | 2 | 156 | 2 | 32991341 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 25691062 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 12778076 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 21785467 | ||
| Interaction | FEV interactions | NCOA3 NCOA6 EP400 FOXP2 MNX1 MAML1 BCL9 ZNF462 NCOR1 KMT2D YAP1 NIPBL EP300 ZMYM4 PRRC2B CBX2 | 3.91e-12 | 203 | 154 | 16 | int:FEV |
| Interaction | KLF5 interactions | NCOA3 NCOA6 XRN2 EP400 MAML1 BCL9 NCOR1 KMT2D UBE2I YAP1 TP63 NIPBL EP300 ZMYM4 PRRC2B | 2.69e-11 | 195 | 154 | 15 | int:KLF5 |
| Interaction | EGR2 interactions | NCOA3 NCOA6 EP400 FOXP2 MAML1 BCL9 ZNF462 NCOR1 KMT2D UBE2I NIPBL EP300 ZMYM4 PRRC2B | 5.52e-11 | 171 | 154 | 14 | int:EGR2 |
| Interaction | AR interactions | TPR NCOA3 DDX19A NCOA6 XRN2 EP400 MYO6 MAML1 ACTN4 MED13L DCC BCL9 MYEF2 ZNF462 NCOR1 KMT2D MLH3 MTA3 UBE2I YAP1 KIAA1217 NR0B1 MED23 TNS1 NIPBL FKBP4 EP300 ZMYM4 PRRC2B | 4.00e-10 | 992 | 154 | 29 | int:AR |
| Interaction | NUP35 interactions | NCOA3 DDX19A NCOA6 RBMS2 RC3H1 MAML1 TNRC6B BCL9 MYEF2 PHAF1 NCOR1 KMT2D NUP155 UBE2I AFDN CNOT2 FKBP4 EP300 PRRC2B | 6.42e-10 | 424 | 154 | 19 | int:NUP35 |
| Interaction | TBXT interactions | NCOA3 NCOA6 MNX1 MAML1 BCL9 NCOR1 KMT2D YAP1 NIPBL EP300 ZMYM4 | 1.43e-09 | 116 | 154 | 11 | int:TBXT |
| Interaction | TNRC6A interactions | NCOA6 RC3H1 MKRN2 TNRC6B NUP155 FAM120C CEP250 FBXO42 AFDN MED23 ANAPC7 CNOT2 TP53BP1 PRRC2B DCP1A | 4.17e-09 | 280 | 154 | 15 | int:TNRC6A |
| Interaction | PAX8 interactions | 1.35e-08 | 111 | 154 | 10 | int:PAX8 | |
| Interaction | SMG7 interactions | NCOA3 NCOA6 XRN2 RC3H1 MKRN2 MAML1 TNRC6B BCL9 NCOR1 KMT2D FAM120C FBXO42 CNOT2 PRRC2B DCP1A | 2.40e-08 | 319 | 154 | 15 | int:SMG7 |
| Interaction | FMR1 interactions | NCOA3 ZSCAN12 RC3H1 IQSEC2 MKRN2 APC TNRC6B ACTN4 BCL9 NCOR1 UBE2I PLPPR4 FAM120C KIAA1217 BSN TNS1 NIPBL TP53BP1 PRRC2B | 2.91e-08 | 536 | 154 | 19 | int:FMR1 |
| Interaction | CEP85 interactions | RPGRIP1 RC3H1 MKRN2 APC TNRC6B NUP155 FAM120C FBXO42 CNOT2 PRRC2B DCP1A | 7.43e-08 | 169 | 154 | 11 | int:CEP85 |
| Interaction | CRX interactions | NCOA3 EP400 FOXP2 MNX1 MAML1 BCL9 ZNF462 KMT2D NIPBL EP300 ZMYM4 PRRC2B NPAS2 | 8.06e-08 | 254 | 154 | 13 | int:CRX |
| Interaction | SOX2 interactions | NCOA3 NCOA6 TCF12 EP400 MNX1 RBMS2 MAML1 ACTN4 SCEL MED13L BCL9 ITIH4 MYEF2 ZNF462 NCOR1 KMT2D MTA3 UBE2I CCT5 YAP1 TP63 KIAA1217 NAV3 ASCC3 ANAPC7 NIPBL FKBP4 EP300 PRRC2B CBX2 VAT1 | 9.30e-08 | 1422 | 154 | 31 | int:SOX2 |
| Interaction | ALG13 interactions | NCOA3 RBMS2 RC3H1 MKRN2 TNRC6B BCL9 NCOR1 KMT2D FAM120C EP300 PRRC2B | 1.67e-07 | 183 | 154 | 11 | int:ALG13 |
| Interaction | HNF4A interactions | NCOA3 NCOA6 EP400 ISL1 ZNF462 NCOR1 KMT2D UBE2I NR0B1 MED23 NIPBL EP300 ZMYM4 | 2.02e-07 | 275 | 154 | 13 | int:HNF4A |
| Interaction | KDM1A interactions | TPR NCOA3 EP400 MKRN2 APC TNRC6B ISL1 PHC1 ZNF462 NCOR1 KMT2D MTA3 UBE2I YAP1 KIAA1217 NR0B1 ASCC3 MED23 FKBP4 EP300 ZMYM4 TP53BP1 TP53BP2 DCP1A | 2.03e-07 | 941 | 154 | 24 | int:KDM1A |
| Interaction | TBR1 interactions | 2.13e-07 | 113 | 154 | 9 | int:TBR1 | |
| Interaction | HNF1B interactions | NCOA3 EP400 MAML1 BCL9 NCOR1 KMT2D YAP1 NIPBL EP300 ZMYM4 PRRC2B | 2.44e-07 | 190 | 154 | 11 | int:HNF1B |
| Interaction | CEP192 interactions | MYO6 MKRN2 ACBD5 TNRC6B NUP155 FAM120C FBXO42 AFDN CNOT2 PRRC2B DCP1A | 2.71e-07 | 192 | 154 | 11 | int:CEP192 |
| Interaction | GARRE1 interactions | RC3H1 MKRN2 ACBD5 TNRC6B FAM120C FBXO42 SIK2 CNOT2 PRRC2B DCP1A | 6.41e-07 | 167 | 154 | 10 | int:GARRE1 |
| Interaction | PAX9 interactions | 7.04e-07 | 130 | 154 | 9 | int:PAX9 | |
| Interaction | CEBPA interactions | RPGRIP1 NCOA3 NCOA6 XRN2 TCF12 UBQLN1 EP400 MAML1 ACTN4 MED13L BCL9 NCOR1 TAOK3 KMT2D MTA3 UBE2I CCT5 RBMX SEPTIN14 MED23 ANAPC7 NIPBL FKBP4 EP300 ZMYM4 TP53BP1 PRRC2B | 8.03e-07 | 1245 | 154 | 27 | int:CEBPA |
| Interaction | GCM1 interactions | 8.71e-07 | 68 | 154 | 7 | int:GCM1 | |
| Interaction | TLX1 interactions | 9.85e-07 | 175 | 154 | 10 | int:TLX1 | |
| Interaction | TEAD1 interactions | 1.04e-06 | 176 | 154 | 10 | int:TEAD1 | |
| Interaction | PATL1 interactions | RC3H1 MKRN2 APC TNRC6B FAM120C CNOT2 EP300 PRRC2B PHLDB2 DCP1A | 1.09e-06 | 177 | 154 | 10 | int:PATL1 |
| Interaction | ERG interactions | NCOA3 NCOA6 XRN2 MAML1 XRCC4 BCL9 NCOR1 KMT2D NIPBL EP300 PRRC2B | 1.20e-06 | 223 | 154 | 11 | int:ERG |
| Interaction | NR1I2 interactions | 1.70e-06 | 48 | 154 | 6 | int:NR1I2 | |
| Interaction | TNRC6B interactions | RPGRIP1 RC3H1 MKRN2 TNRC6B NUP155 FAM120C YAP1 AFDN MED23 CNOT2 PRRC2B DCP1A | 1.83e-06 | 282 | 154 | 12 | int:TNRC6B |
| Interaction | SLX4 interactions | TCF12 EP400 MAML1 ACTN4 ZNF462 NCOR1 MLH3 NUP155 UBE2I CCT5 RBMX ASCC3 MED23 NIPBL ZMYM4 TP53BP1 PRRC2B | 1.88e-06 | 572 | 154 | 17 | int:SLX4 |
| Interaction | FAM120C interactions | MYO6 RBMS2 RC3H1 APC TNRC6B NUP155 FAM120C CNOT2 FKBP4 PRRC2B | 2.18e-06 | 191 | 154 | 10 | int:FAM120C |
| Interaction | KLF15 interactions | NCOA3 XRN2 EP400 MAML1 BCL9 NCOR1 KMT2D YAP1 NIPBL EP300 ZMYM4 PRRC2B | 2.44e-06 | 290 | 154 | 12 | int:KLF15 |
| Interaction | CREBBP interactions | NCOA3 NCOA6 TCF12 MAML1 APC NCOR1 KMT2D SEPTIN3 UBE2I YAP1 MAML2 MED23 ANAPC7 EP300 TP53BP1 TP53BP2 NPAS2 | 3.50e-06 | 599 | 154 | 17 | int:CREBBP |
| Interaction | SP7 interactions | NCOA3 NCOA6 XRN2 EP400 MNX1 MAML1 BCL9 NCOR1 KMT2D NIPBL EP300 PRRC2B | 3.97e-06 | 304 | 154 | 12 | int:SP7 |
| Interaction | IRF4 interactions | 3.98e-06 | 85 | 154 | 7 | int:IRF4 | |
| Interaction | HDAC4 interactions | TPR MKRN2 ADGRB3 APC TNRC6B ACTN4 MYEF2 NCOR1 NWD2 NF1 NUP155 UBE2I CCT5 FAM120C NAV3 TP53BP1 PRRC2B PHLDB2 DCP1A | 4.19e-06 | 744 | 154 | 19 | int:HDAC4 |
| Interaction | NFKB1 interactions | NCOA3 NCOA6 POLR1A ACBD5 XRCC4 PTGS2 NCOR1 TP63 CNOT2 EP300 TP53BP1 TP53BP2 | 4.39e-06 | 307 | 154 | 12 | int:NFKB1 |
| Interaction | PAX7 interactions | 5.04e-06 | 124 | 154 | 8 | int:PAX7 | |
| Interaction | N4BP2 interactions | 5.41e-06 | 89 | 154 | 7 | int:N4BP2 | |
| Interaction | MOV10 interactions | TCTN3 XRN2 TCF12 POLR1A MYO6 RBMS2 RC3H1 MKRN2 OGFOD2 ACBD5 DNAJB4 TNRC6B XRCC4 DICER1 CLHC1 FAM120C YAP1 CEP250 WDR83OS EGFLAM ASCC3 EP300 ZMYM4 TP53BP1 PRRC2B DCP1A | 5.57e-06 | 1297 | 154 | 26 | int:MOV10 |
| Interaction | SIRT6 interactions | MYH7 XRN2 POLR1A EP400 MKRN2 APC DICER1 MYEF2 HPS3 NF1 NUP155 CCT5 ASCC3 MED23 ANAPC7 EP300 TP53BP1 | 6.54e-06 | 628 | 154 | 17 | int:SIRT6 |
| Interaction | SOX10 interactions | 6.75e-06 | 92 | 154 | 7 | int:SOX10 | |
| Interaction | DCAF4 interactions | RBMS2 RC3H1 MKRN2 ASH1L APC TNRC6B CCT5 FAM120C ASCC3 FKBP4 EP300 PRRC2B PHLDB2 | 6.98e-06 | 378 | 154 | 13 | int:DCAF4 |
| Interaction | SOX9 interactions | 9.59e-06 | 97 | 154 | 7 | int:SOX9 | |
| Interaction | CCDC8 interactions | TPR DDX19A POLR1A EP400 IQSEC2 ACTN4 DICER1 NF1 SLC12A2 NUP155 RBMX CEP250 AFDN ASCC3 ANAPC7 NIPBL PHLDB2 | 1.15e-05 | 656 | 154 | 17 | int:CCDC8 |
| Interaction | AGO1 interactions | 1.18e-05 | 183 | 154 | 9 | int:AGO1 | |
| Interaction | NR3C1 interactions | SCFD2 NCOA3 DDX19A NCOA6 MYO6 MAML1 MUC16 BCL9 MYEF2 NCOR1 KMT2D NF1 UBE2I FBXO42 NR0B1 BSN NIPBL FKBP4 EP300 PRRC2B VAT1 | 1.70e-05 | 974 | 154 | 21 | int:NR3C1 |
| Interaction | YTHDF3 interactions | RBMS2 RC3H1 MKRN2 ACBD5 TNRC6B FAM120C FBXO42 CNOT2 PRRC2B DCP1A | 2.02e-05 | 246 | 154 | 10 | int:YTHDF3 |
| Interaction | EP300 interactions | NCOA3 NCOA6 XRN2 TCF12 UBQLN1 VPS45 MKRN2 MAML1 PTGS2 ARF5 NCOR1 KMT2D UBE2I YAP1 TP63 RBMX SIK2 MAML2 BSN TMC5 MED23 ANAPC7 EP300 TP53BP1 TP53BP2 NPAS2 | 2.16e-05 | 1401 | 154 | 26 | int:EP300 |
| Interaction | RELA interactions | NCOA3 NCOA6 UBQLN1 POLR1A MKRN2 ACTN4 ISL1 KMT2D YAP1 TP63 MED23 EP300 TP53BP1 TP53BP2 | 2.21e-05 | 485 | 154 | 14 | int:RELA |
| Interaction | WWTR1 interactions | NCOA6 EP400 TNRC6B NCOR1 KMT2D YAP1 TP63 AFDN ASCC3 EP300 TP53BP1 PRRC2B TP53BP2 | 2.24e-05 | 422 | 154 | 13 | int:WWTR1 |
| Interaction | SEC16A interactions | MYO6 RC3H1 TNRC6B NUP155 FAM120C YAP1 KIAA1217 CEP250 FBXO42 MED23 CNOT2 PRRC2B DCP1A | 2.47e-05 | 426 | 154 | 13 | int:SEC16A |
| Interaction | PAX6 interactions | NCOA3 NCOA6 EP400 MNX1 BCL9 ZNF462 NCOR1 KMT2D NIPBL EP300 ZMYM4 PRRC2B | 2.55e-05 | 366 | 154 | 12 | int:PAX6 |
| Interaction | APC2 interactions | 2.59e-05 | 23 | 154 | 4 | int:APC2 | |
| Interaction | NGLY1 interactions | 2.74e-05 | 77 | 154 | 6 | int:NGLY1 | |
| Interaction | FOS interactions | EPHB2 NCOA3 NCOA6 TCF12 EP400 MYO6 BCL9 NCOR1 KMT2D UBE2I EP300 | 2.90e-05 | 312 | 154 | 11 | int:FOS |
| Interaction | HELZ interactions | RBMS2 RC3H1 MKRN2 TNRC6B NUP155 FAM120C FBXO42 CNOT2 PRRC2B DCP1A | 2.93e-05 | 257 | 154 | 10 | int:HELZ |
| Interaction | RBMS1 interactions | 3.13e-05 | 207 | 154 | 9 | int:RBMS1 | |
| Interaction | HNRNPD interactions | NCOA3 DNAH3 VPS45 RC3H1 ACTN4 DICER1 PTGS2 MYEF2 NCOR1 UBE2I YAP1 TP63 RBMX EP300 ZMYM4 TP53BP1 | 3.15e-05 | 638 | 154 | 16 | int:HNRNPD |
| Interaction | ESRRB interactions | NCOA3 EP400 MED13L ZNF462 KMT2D MTA3 KIAA1217 NR0B1 ASCC3 MED23 | 3.46e-05 | 262 | 154 | 10 | int:ESRRB |
| Interaction | ETS1 interactions | 4.05e-05 | 121 | 154 | 7 | int:ETS1 | |
| Interaction | MKRN2 interactions | XRN2 FOXP2 MYO6 RBMS2 RC3H1 MKRN2 APC TNRC6B SEMA6A ASCC3 EP300 PRRC2B | 4.17e-05 | 385 | 154 | 12 | int:MKRN2 |
| Interaction | ZC3H7A interactions | 4.21e-05 | 215 | 154 | 9 | int:ZC3H7A | |
| Interaction | APC interactions | TPR MYO6 MKRN2 APC DCC PTGS2 FAM120C CEP250 FBXO42 NAV3 AFDN MBD5 | 4.61e-05 | 389 | 154 | 12 | int:APC |
| Interaction | PAX2 interactions | 4.80e-05 | 85 | 154 | 6 | int:PAX2 | |
| Interaction | GSC interactions | 5.48e-05 | 87 | 154 | 6 | int:GSC | |
| Interaction | R3HDM2 interactions | 6.09e-05 | 129 | 154 | 7 | int:R3HDM2 | |
| Interaction | GIGYF1 interactions | 6.63e-05 | 177 | 154 | 8 | int:GIGYF1 | |
| Interaction | GAS5 interactions | 6.90e-05 | 11 | 154 | 3 | int:GAS5 | |
| Interaction | CTBP1 interactions | EP400 FOXP2 PDE6B MAML1 APC ARF5 NCOR1 UBE2I MAML2 MED23 EP300 PRRC2B | 6.95e-05 | 406 | 154 | 12 | int:CTBP1 |
| Interaction | AGO2 interactions | NCOA6 RC3H1 MKRN2 TNRC6B ACTN4 DICER1 FAM120C TP63 CEP250 CNOT2 FKBP4 PRRC2B DCP1A | 7.06e-05 | 472 | 154 | 13 | int:AGO2 |
| Interaction | ZFP36 interactions | 7.76e-05 | 181 | 154 | 8 | int:ZFP36 | |
| Interaction | NR1H3 interactions | 8.07e-05 | 58 | 154 | 5 | int:NR1H3 | |
| Interaction | TLX3 interactions | 8.33e-05 | 291 | 154 | 10 | int:TLX3 | |
| Interaction | NXF1 interactions | TPR TCTN3 DDX19A XRN2 TCF12 UBQLN1 POLR1A MYO6 RBMS2 MKRN2 ACBD5 TNRC6B HPS3 NF1 NUP155 UBE2I YAP1 RBMX CEP250 ASCC3 ZMYM4 TP53BP1 PRRC2B TP53BP2 | 8.63e-05 | 1345 | 154 | 24 | int:NXF1 |
| Interaction | NUP43 interactions | NCOA6 XRN2 EP400 ASH1L APC TNRC6B NSD3 ZNF462 NCOR1 KMT2D CCT5 RBMX CEP250 NIPBL ZMYM4 | 9.20e-05 | 625 | 154 | 15 | int:NUP43 |
| Interaction | PABPC1 interactions | DDX19A RBMS2 RC3H1 MKRN2 TNRC6B ACTN4 CCT5 YAP1 RBMX CEP250 BCAR3 ASCC3 EP300 PRRC2B DCP1A VAT1 | 9.26e-05 | 699 | 154 | 16 | int:PABPC1 |
| Interaction | CDC5L interactions | TPR RNF130 DDX19A XRN2 FOXP2 RBMS2 MKRN2 ARF5 HSPA12A NF1 NUP155 CCT5 FAM120C RBMX ANAPC7 NIPBL EP300 TP53BP2 | 9.64e-05 | 855 | 154 | 18 | int:CDC5L |
| Interaction | GATA3 interactions | 9.74e-05 | 187 | 154 | 8 | int:GATA3 | |
| Interaction | PAIP2 interactions | 1.20e-04 | 63 | 154 | 5 | int:PAIP2 | |
| Interaction | PUM2 interactions | 1.22e-04 | 144 | 154 | 7 | int:PUM2 | |
| Interaction | MYOD1 interactions | 1.26e-04 | 194 | 154 | 8 | int:MYOD1 | |
| Interaction | TRIM28 interactions | DDX19A XRN2 POLR1A MYO6 RC3H1 ZNF462 NCOR1 UBE2I CCT5 UBE3D YAP1 RBMX CEP250 TRIM17 NR0B1 SIK2 ASCC3 DNAH5 DNAH8 ANAPC7 NIPBL FKBP4 EP300 ZMYM4 TP53BP1 | 1.35e-04 | 1474 | 154 | 25 | int:TRIM28 |
| Interaction | YTHDF2 interactions | RBMS2 RC3H1 MKRN2 ACBD5 TNRC6B SLC15A3 FAM120C CNOT2 PRRC2B DCP1A | 1.47e-04 | 312 | 154 | 10 | int:YTHDF2 |
| Interaction | RNF214 interactions | 1.48e-04 | 104 | 154 | 6 | int:RNF214 | |
| Interaction | KCTD13 interactions | SYN3 MYO6 VPS45 IQSEC2 APC ACTN4 PTGS2 MYEF2 ARF5 HSPA12A NWD2 NF1 PLPPR4 CCT5 FAM120C KIAA1217 RBMX ARHGAP44 AFDN BSN TNS1 PRRC2B TP53BP2 SCAI | 1.49e-04 | 1394 | 154 | 24 | int:KCTD13 |
| Interaction | GATA2 interactions | 1.50e-04 | 199 | 154 | 8 | int:GATA2 | |
| Interaction | RBPJ interactions | 1.51e-04 | 254 | 154 | 9 | int:RBPJ | |
| Interaction | TLE3 interactions | NCOA3 MYH7 TCF12 MAML1 BCL9 NCOR1 KMT2D NR0B1 MED23 NIPBL EP300 | 1.53e-04 | 376 | 154 | 11 | int:TLE3 |
| Interaction | IQCK interactions | 1.73e-04 | 3 | 154 | 2 | int:IQCK | |
| Interaction | AGO3 interactions | 1.77e-04 | 153 | 154 | 7 | int:AGO3 | |
| Interaction | DPY30 interactions | 1.77e-04 | 204 | 154 | 8 | int:DPY30 | |
| Interaction | ETV4 interactions | 1.85e-04 | 69 | 154 | 5 | int:ETV4 | |
| Interaction | SIRT7 interactions | TPR XRN2 POLR1A ACTN4 DICER1 MYEF2 NF1 NUP155 CCT5 RBMX AFDN ASCC3 NIPBL FKBP4 TP53BP1 PRRC2B | 1.89e-04 | 744 | 154 | 16 | int:SIRT7 |
| Interaction | CNOT3 interactions | 1.96e-04 | 207 | 154 | 8 | int:CNOT3 | |
| Interaction | MED23 interactions | 2.13e-04 | 266 | 154 | 9 | int:MED23 | |
| Interaction | PIWIL1 interactions | 2.28e-04 | 16 | 154 | 3 | int:PIWIL1 | |
| Interaction | TDRD3 interactions | 2.31e-04 | 212 | 154 | 8 | int:TDRD3 | |
| Interaction | TBX2 interactions | 2.42e-04 | 40 | 154 | 4 | int:TBX2 | |
| Interaction | SOX5 interactions | 2.52e-04 | 162 | 154 | 7 | int:SOX5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq26 | 2.80e-05 | 171 | 156 | 6 | chrXq26 | |
| Cytoband | Xq26.3 | 8.32e-05 | 67 | 156 | 4 | Xq26.3 | |
| GeneFamily | Dyneins, axonemal | 3.86e-08 | 17 | 107 | 5 | 536 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 3.19e-07 | 25 | 107 | 5 | 775 | |
| GeneFamily | Olfactory receptors, family 3 | 5.12e-04 | 6 | 107 | 2 | 150 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 7.26e-04 | 181 | 107 | 6 | 694 | |
| GeneFamily | Nucleoporins | 8.82e-04 | 32 | 107 | 3 | 1051 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.06e-03 | 34 | 107 | 3 | 487 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 1.84e-03 | 11 | 107 | 2 | 1168 | |
| GeneFamily | Septins | 2.59e-03 | 13 | 107 | 2 | 732 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.81e-03 | 53 | 107 | 3 | 532 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.45e-03 | 17 | 107 | 2 | 486 | |
| Coexpression | GSE14308_TH2_VS_TH1_UP | DDX19A RBMS2 MAML1 APC ACTN4 TAOK3 RBMX WDR83OS BCAR3 ASCC3 VAT1 | 3.06e-08 | 199 | 155 | 11 | M3359 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPHB2 NCOA3 TCF12 APC MED13L XRCC4 DICER1 PTPN4 TAOK3 YAP1 NAV3 BCAR3 ASCC3 NIPBL CNOT2 ZMYM4 TP53BP1 TP53BP2 | 3.36e-06 | 856 | 155 | 18 | M4500 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL | 3.42e-06 | 69 | 155 | 6 | M45681 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 3.76e-06 | 323 | 155 | 11 | M9150 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.26e-05 | 300 | 155 | 10 | M8702 | |
| Coexpression | LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3 | 1.28e-05 | 181 | 155 | 8 | M39225 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | 2.54e-05 | 199 | 155 | 8 | M6519 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | 2.64e-05 | 200 | 155 | 8 | M9463 | |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN | 2.64e-05 | 200 | 155 | 8 | M9459 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL | 3.65e-05 | 104 | 155 | 6 | M45682 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 6.83e-05 | 169 | 155 | 7 | M39230 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.77e-09 | 195 | 155 | 10 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.56e-08 | 192 | 155 | 9 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.44e-07 | 181 | 155 | 8 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 3.01e-07 | 186 | 155 | 8 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.26e-07 | 188 | 155 | 8 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 3.26e-07 | 188 | 155 | 8 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.53e-07 | 190 | 155 | 8 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 3.68e-07 | 191 | 155 | 8 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 3.83e-07 | 192 | 155 | 8 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.14e-07 | 194 | 155 | 8 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.83e-07 | 198 | 155 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.02e-07 | 199 | 155 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.21e-07 | 200 | 155 | 8 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-06 | 169 | 155 | 7 | cd16e8462ee09877be962fbd9a3badcb825820b0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.54e-06 | 173 | 155 | 7 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 2.63e-06 | 174 | 155 | 7 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-06 | 179 | 155 | 7 | 3edcd1356e49b1f5514c585861999e079ca5e579 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.30e-06 | 180 | 155 | 7 | 30cf3c7ee29694eaccb89bf8053a82037d5c9f1d | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-06 | 181 | 155 | 7 | 1db1eb7d330a7e5090994007ae287e11f0a74450 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-06 | 181 | 155 | 7 | 06174ce9240c9261c0f51a1b0d875335d60722e5 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.81e-06 | 184 | 155 | 7 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.81e-06 | 184 | 155 | 7 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-06 | 184 | 155 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.81e-06 | 184 | 155 | 7 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.95e-06 | 185 | 155 | 7 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.39e-06 | 188 | 155 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.39e-06 | 188 | 155 | 7 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.39e-06 | 188 | 155 | 7 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.39e-06 | 188 | 155 | 7 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 4.55e-06 | 189 | 155 | 7 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.71e-06 | 190 | 155 | 7 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.87e-06 | 191 | 155 | 7 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.87e-06 | 191 | 155 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.04e-06 | 192 | 155 | 7 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.22e-06 | 193 | 155 | 7 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.22e-06 | 193 | 155 | 7 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.40e-06 | 194 | 155 | 7 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.40e-06 | 194 | 155 | 7 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.58e-06 | 195 | 155 | 7 | 68f4cc84b5ae7f4159b780c78e4b66c94211779a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.58e-06 | 195 | 155 | 7 | 2a1863f4b9fe73c30b0b1acf9b12fc98ef65040f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.77e-06 | 196 | 155 | 7 | eb68f7954e7c2f86d05e740e95b6e74805a6053f | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 6.17e-06 | 198 | 155 | 7 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.37e-06 | 199 | 155 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.37e-06 | 199 | 155 | 7 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.37e-06 | 199 | 155 | 7 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.37e-06 | 199 | 155 | 7 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 6.59e-06 | 200 | 155 | 7 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-OPC_related-Oligodendrocyte/OPC|1m / Sample Type, Dataset, Time_group, and Cell type. | 6.59e-06 | 200 | 155 | 7 | 80cec67b7557465320a847ba959a8a13f7c51566 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-06 | 200 | 155 | 7 | f0c338877e39226a90c4effe12f6501d33542a73 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.59e-06 | 200 | 155 | 7 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-OPC_related|1m / Sample Type, Dataset, Time_group, and Cell type. | 6.59e-06 | 200 | 155 | 7 | 8dafb90b418f91a0fb56c97db06233d3eca358dc | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-capillary_endothelial_Hpgd-CA4_high|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.67e-05 | 154 | 155 | 6 | 212c340a096a3a9669d1aebd61c045cf1402a868 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.23e-05 | 162 | 155 | 6 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.83e-05 | 169 | 155 | 6 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.83e-05 | 169 | 155 | 6 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.44e-05 | 175 | 155 | 6 | 442f261a3b2c4d2523f7d4089178f8c79cac2f0f | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.44e-05 | 175 | 155 | 6 | 35fb7735dd3355476fe60404833cb60bd066bcf1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.78e-05 | 178 | 155 | 6 | ad187db4c40b9078d54dd915c143e0172b2f47b8 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 3.90e-05 | 179 | 155 | 6 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.90e-05 | 179 | 155 | 6 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.90e-05 | 179 | 155 | 6 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.02e-05 | 180 | 155 | 6 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 181 | 155 | 6 | 57f0cc749ae8b6a3d77e2af31f9a6e4739c57049 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 181 | 155 | 6 | d01b35cc2fc57991a35be6a06cb7351fbabd9a11 | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 4.41e-05 | 183 | 155 | 6 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.55e-05 | 184 | 155 | 6 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 4.55e-05 | 184 | 155 | 6 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 4.69e-05 | 185 | 155 | 6 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 4.97e-05 | 187 | 155 | 6 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.12e-05 | 188 | 155 | 6 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 5.12e-05 | 188 | 155 | 6 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 188 | 155 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.12e-05 | 188 | 155 | 6 | 07705bed928683470a52c8ccfa40ffb9a0971318 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 5.12e-05 | 188 | 155 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | Entopeduncular-Endothelial|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.12e-05 | 188 | 155 | 6 | 94774652fd42bad5012356672ffac8b6d2c22d37 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.28e-05 | 189 | 155 | 6 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | Substantia_nigra-Endothelial|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.28e-05 | 189 | 155 | 6 | bef8234bd9c4d6e3cdef0791d8066b39ba56ebba | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.28e-05 | 189 | 155 | 6 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 5.28e-05 | 189 | 155 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 5.43e-05 | 190 | 155 | 6 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 5.59e-05 | 191 | 155 | 6 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.59e-05 | 191 | 155 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.59e-05 | 191 | 155 | 6 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.76e-05 | 192 | 155 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.76e-05 | 192 | 155 | 6 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.76e-05 | 192 | 155 | 6 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 5.76e-05 | 192 | 155 | 6 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-05 | 192 | 155 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.93e-05 | 193 | 155 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.10e-05 | 194 | 155 | 6 | fc40ab57be3a15c043e3414c2c678c1dc52207c8 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 6.27e-05 | 195 | 155 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 6.27e-05 | 195 | 155 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 6.27e-05 | 195 | 155 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 6.27e-05 | 195 | 155 | 6 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 6.45e-05 | 196 | 155 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 121 | 155 | 5 | e82c9e10b98c8d7ad828cf8ac19a2342014be2ba | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.64e-05 | 197 | 155 | 6 | b0fb5774525ba05f60c635d42f14bb8d79bff17c | |
| ToppCell | Severe_COVID-19-Epithelial-transitional_Epi|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 6.64e-05 | 197 | 155 | 6 | 5ad3cd4c77016e862041baac3076f8cc0f75c417 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.64e-05 | 197 | 155 | 6 | bbb7c106d5b96b8e95aeb3e5c293e104fceea234 | |
| ToppCell | Biopsy_IPF-Epithelial-AT1|Biopsy_IPF / Sample group, Lineage and Cell type | 6.83e-05 | 198 | 155 | 6 | 75bdecbe111fededf6082b11de18b84ca308ef6d | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 2.43e-06 | 171 | 153 | 9 | 7535_DN | |
| Drug | Bmps | 7.06e-06 | 69 | 153 | 6 | CID004620597 | |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 7.41e-06 | 196 | 153 | 9 | 6782_DN | |
| Drug | Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; PC3; HT_HG-U133A | 8.37e-06 | 199 | 153 | 9 | 6624_DN | |
| Disease | neuroimaging measurement | SCFD2 CELF4 FOXP2 APC TNRC6B ACTN4 DCC XRCC4 ZNF462 NCOR1 PTPN4 NF1 TP63 NAV3 KIAA1755 TMC5 TNS1 SCAI | 5.47e-06 | 1069 | 145 | 18 | EFO_0004346 |
| Disease | Colorectal cancer | 8.99e-06 | 27 | 145 | 4 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 8.99e-06 | 27 | 145 | 4 | 114500 | |
| Disease | Neoplasm of the large intestine | 8.99e-06 | 27 | 145 | 4 | cv:C0009404 | |
| Disease | Bladder Exstrophy | 2.40e-05 | 2 | 145 | 2 | C0005689 | |
| Disease | Glioblastoma | 4.50e-05 | 79 | 145 | 5 | C0017636 | |
| Disease | Colorectal Carcinoma | DNAH3 APC DCC PTGS2 HPS3 MLH3 NF1 YAP1 TP63 HRH1 DNAH8 EP300 ZMYM4 | 4.57e-05 | 702 | 145 | 13 | C0009402 |
| Disease | Giant Cell Glioblastoma | 6.04e-05 | 84 | 145 | 5 | C0334588 | |
| Disease | Polyposis, Adenomatous Intestinal | 6.21e-05 | 16 | 145 | 3 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 6.21e-05 | 16 | 145 | 3 | C2713443 | |
| Disease | feeling nervous measurement | 7.15e-05 | 87 | 145 | 5 | EFO_0009597 | |
| Disease | Adenomatous Polyposis Coli | 7.51e-05 | 17 | 145 | 3 | C0032580 | |
| Disease | Alzheimer disease, APOE carrier status | 1.26e-04 | 98 | 145 | 5 | EFO_0007659, MONDO_0004975 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 1.43e-04 | 4 | 145 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Glioblastoma Multiforme | 2.26e-04 | 111 | 145 | 5 | C1621958 | |
| Disease | Intestinal Polyps | 2.38e-04 | 5 | 145 | 2 | C0021846 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 2.78e-04 | 26 | 145 | 3 | C0009405 | |
| Disease | Mammary Carcinoma, Human | NCOA3 PTGS2 NCOR1 KMT2D CCT5 YAP1 BCAR3 EP300 TP53BP1 TP53BP2 | 2.83e-04 | 525 | 145 | 10 | C4704874 |
| Disease | Mammary Neoplasms, Human | NCOA3 PTGS2 NCOR1 KMT2D CCT5 YAP1 BCAR3 EP300 TP53BP1 TP53BP2 | 2.83e-04 | 525 | 145 | 10 | C1257931 |
| Disease | fish consumption measurement | 2.83e-04 | 64 | 145 | 4 | EFO_0010139 | |
| Disease | Mammary Neoplasms | NCOA3 PTGS2 NCOR1 KMT2D CCT5 YAP1 BCAR3 EP300 TP53BP1 TP53BP2 | 2.91e-04 | 527 | 145 | 10 | C1458155 |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 3.12e-04 | 27 | 145 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | breast carcinoma (is_marker_for) | 3.18e-04 | 66 | 145 | 4 | DOID:3459 (is_marker_for) | |
| Disease | histidine measurement | 3.18e-04 | 66 | 145 | 4 | EFO_0009769 | |
| Disease | colorectal cancer (is_implicated_in) | 3.36e-04 | 121 | 145 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | Breast Carcinoma | NCOA3 PTGS2 NCOR1 KMT2D CCT5 YAP1 BCAR3 EP300 TP53BP1 TP53BP2 | 3.43e-04 | 538 | 145 | 10 | C0678222 |
| Disease | Pure gonadal dysgenesis 46,XY | 3.55e-04 | 6 | 145 | 2 | cv:C2936694 | |
| Disease | age at diagnosis, substance-related disorder | 3.55e-04 | 6 | 145 | 2 | EFO_0004918, MONDO_0002494 | |
| Disease | Strabismus | 3.87e-04 | 29 | 145 | 3 | HP_0000486 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 3.87e-04 | 29 | 145 | 3 | C1333990 | |
| Disease | Schizophrenia | CACNA1F SYN3 FOXP2 APC DCC XRCC4 BCL9 DICER1 PTGS2 HSPA12A SLC12A2 HRH1 NPAS2 | 4.33e-04 | 883 | 145 | 13 | C0036341 |
| Disease | Colorectal Neoplasms | 4.57e-04 | 277 | 145 | 7 | C0009404 | |
| Disease | ulcerative colitis (implicated_via_orthology) | 4.96e-04 | 7 | 145 | 2 | DOID:8577 (implicated_via_orthology) | |
| Disease | legumain measurement | 4.96e-04 | 7 | 145 | 2 | EFO_0020530 | |
| Disease | inter-alpha-trypsin inhibitor heavy chain h4 measurement | 4.96e-04 | 7 | 145 | 2 | EFO_0020481 | |
| Disease | ovarian neoplasm | 5.37e-04 | 134 | 145 | 5 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 5.94e-04 | 137 | 145 | 5 | C1140680 | |
| Disease | systolic blood pressure, body mass index | 6.22e-04 | 34 | 145 | 3 | EFO_0004340, EFO_0006335 | |
| Disease | Profound Mental Retardation | 6.34e-04 | 139 | 145 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 6.34e-04 | 139 | 145 | 5 | C0025363 | |
| Disease | Mental deficiency | 6.34e-04 | 139 | 145 | 5 | C0917816 | |
| Disease | Bladder Neoplasm | 6.55e-04 | 140 | 145 | 5 | C0005695 | |
| Disease | Bone neoplasms | 6.59e-04 | 8 | 145 | 2 | C0005967 | |
| Disease | Malignant Bone Neoplasm | 6.59e-04 | 8 | 145 | 2 | C0279530 | |
| Disease | disease recurrence, unipolar depression, bipolar disorder, schizophrenia | 6.59e-04 | 8 | 145 | 2 | EFO_0003761, EFO_0004952, MONDO_0004985, MONDO_0005090 | |
| Disease | ovarian cancer (implicated_via_orthology) | 6.59e-04 | 8 | 145 | 2 | DOID:2394 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of urinary bladder | 6.76e-04 | 141 | 145 | 5 | C0005684 | |
| Disease | diet measurement | NCOA6 CELF4 FOXP2 ADGRB3 TNRC6B DNAH14 NWD2 NF1 FEZF1 KIAA1217 SIK2 MBD5 DNAH5 NIPBL | 6.87e-04 | 1049 | 145 | 14 | EFO_0008111 |
| Disease | lung cancer (implicated_via_orthology) | 8.44e-04 | 9 | 145 | 2 | DOID:1324 (implicated_via_orthology) | |
| Disease | Lynch Syndrome | 8.44e-04 | 9 | 145 | 2 | C4552100 | |
| Disease | underweight body mass index status | 8.44e-04 | 9 | 145 | 2 | EFO_0005936 | |
| Disease | Malignant neoplasm of breast | NCOA3 NCOA6 PTGS2 NCOR1 KMT2D NF1 CCT5 YAP1 BCAR3 TNS1 NIPBL EP300 TP53BP1 TP53BP2 | 8.62e-04 | 1074 | 145 | 14 | C0006142 |
| Disease | Malignant neoplasm of prostate | 9.71e-04 | 616 | 145 | 10 | C0376358 | |
| Disease | urate measurement, bone density | RC3H1 ADGRB3 DNAH14 FEZF1 YAP1 FBXO42 KIAA1755 MAML2 DNAH8 PRRC2B | 1.01e-03 | 619 | 145 | 10 | EFO_0003923, EFO_0004531 |
| Disease | monocyte percentage of leukocytes | POLR1A IQSEC2 MKRN2 MAML1 MED13L JAK2 NF1 UBE2I KIAA1755 MBD5 ZMYM4 | 1.01e-03 | 731 | 145 | 11 | EFO_0007989 |
| Disease | major depressive disorder | 1.03e-03 | 155 | 145 | 5 | MONDO_0002009 | |
| Disease | Craniofacial Abnormalities | 1.06e-03 | 156 | 145 | 5 | C0376634 | |
| Disease | Carcinoma, Transitional Cell | 1.08e-03 | 41 | 145 | 3 | C0007138 | |
| Disease | Anorectal Malformations | 1.08e-03 | 41 | 145 | 3 | C3495676 | |
| Disease | Malignant tumor of colon | 1.16e-03 | 159 | 145 | 5 | C0007102 | |
| Disease | Neurodevelopmental Disorders | 1.16e-03 | 93 | 145 | 4 | C1535926 | |
| Disease | Microphthalmos | 1.28e-03 | 11 | 145 | 2 | C0026010 | |
| Disease | Carcinomatosis | 1.29e-03 | 163 | 145 | 5 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 1.29e-03 | 163 | 145 | 5 | C0205697 | |
| Disease | Undifferentiated carcinoma | 1.29e-03 | 163 | 145 | 5 | C0205698 | |
| Disease | Anaplastic carcinoma | 1.29e-03 | 163 | 145 | 5 | C0205696 | |
| Disease | Adenocarcinoma of large intestine | 1.31e-03 | 96 | 145 | 4 | C1319315 | |
| Disease | Thyroid carcinoma | 1.33e-03 | 44 | 145 | 3 | C0549473 | |
| Disease | Carcinoma | 1.33e-03 | 164 | 145 | 5 | C0007097 | |
| Disease | Pancreatic Neoplasm | 1.52e-03 | 100 | 145 | 4 | C0030297 | |
| Disease | Night blindness, congenital stationary, type 1 | 1.53e-03 | 12 | 145 | 2 | C3501847 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 1.53e-03 | 12 | 145 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 1.53e-03 | 12 | 145 | 2 | C1864877 | |
| Disease | Oligospermia | 1.53e-03 | 12 | 145 | 2 | C0028960 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 1.53e-03 | 12 | 145 | 2 | C1850362 | |
| Disease | X-Linked Csnb | 1.53e-03 | 12 | 145 | 2 | C3711543 | |
| Disease | distal myopathy (implicated_via_orthology) | 1.53e-03 | 12 | 145 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 1.53e-03 | 12 | 145 | 2 | C1848172 | |
| Disease | smoking behavior | 1.53e-03 | 341 | 145 | 7 | EFO_0004318 | |
| Disease | gastroesophageal reflux disease | 1.58e-03 | 101 | 145 | 4 | EFO_0003948 | |
| Disease | Malignant neoplasm of pancreas | 1.64e-03 | 102 | 145 | 4 | C0346647 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 1.67e-03 | 346 | 145 | 7 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | Intellectual Disability | 1.71e-03 | 447 | 145 | 8 | C3714756 | |
| Disease | total blood protein measurement | 1.76e-03 | 449 | 145 | 8 | EFO_0004536 | |
| Disease | hematologic cancer (implicated_via_orthology) | 1.81e-03 | 13 | 145 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | Benign tumor of pancreas | 1.81e-03 | 13 | 145 | 2 | C0347284 | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 1.81e-03 | 13 | 145 | 2 | C4041558 | |
| Disease | Glaucoma, Primary Open Angle | 1.81e-03 | 13 | 145 | 2 | C0339573 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.81e-03 | 49 | 145 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | 3-hydroxy-1-methylpropylmercapturic acid measurement | 1.84e-03 | 352 | 145 | 7 | EFO_0007015 | |
| Disease | mouth morphology measurement | 1.92e-03 | 50 | 145 | 3 | EFO_0007955 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.00e-03 | 566 | 145 | 9 | EFO_0007660, EFO_0008354 | |
| Disease | tetralogy of Fallot (implicated_via_orthology) | 2.10e-03 | 14 | 145 | 2 | DOID:6419 (implicated_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 2.16e-03 | 268 | 145 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | leukemia | 2.53e-03 | 55 | 145 | 3 | C0023418 | |
| Disease | Diffuse Large B-Cell Lymphoma | 2.53e-03 | 55 | 145 | 3 | C0079744 | |
| Disease | Drug habituation | 2.54e-03 | 115 | 145 | 4 | C0013170 | |
| Disease | Drug abuse | 2.54e-03 | 115 | 145 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 2.54e-03 | 115 | 145 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 2.54e-03 | 115 | 145 | 4 | C0236969 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TLLNQPSPMMQRISD | 1101 | P55196 | |
| MVKSPMTQAGLTSPN | 121 | Q09472 | |
| LQSGMPRPAMMSVAQ | 2006 | Q09472 | |
| QAMPSTGMAEQSKRP | 506 | Q96L91 | |
| AGTQRPKNLMQTLME | 796 | Q9Y2D5 | |
| TRLTPQLQMKPMSNR | 2341 | Q9NR48 | |
| ARTGKSPGMMRQLNI | 946 | Q63HQ2 | |
| ATMPESAPNNMTFLK | 681 | Q9H7T0 | |
| MAAGKFASLPRNMPV | 1 | O75815 | |
| MPRSSVNNQPSMKEE | 1311 | O60242 | |
| PKNGSFQPTNEMMLK | 56 | Q5T8D3 | |
| NKQDMPNAMPVSELT | 126 | P84085 | |
| LSNRPAFMPSEGKMV | 366 | O43707 | |
| MKSPALQPLSMAGLQ | 1 | Q9UPY3 | |
| PRNSTMMQAVKTTPR | 336 | Q9NPI6 | |
| GFNRPSKIQEMALPM | 116 | Q9UHL0 | |
| SEGPMKIQTLPNMRS | 381 | Q13625 | |
| MSTNNMSDPRRPNKV | 1 | Q9Y284 | |
| GSMIDMPLLKQAQNT | 316 | Q8N0X4 | |
| TSNPDPAVSRVMNMK | 701 | Q14624 | |
| PKSEMLRSNRNAMQP | 176 | Q9ULI1 | |
| GMAERKTQPSMVSNP | 116 | Q9H000 | |
| MQAMAPQGAPTKSIN | 896 | Q5TC82 | |
| LQPASMMGPLTQQLG | 331 | Q15434 | |
| MNFNMSSSRGPLPVK | 136 | P38159 | |
| QMTIAVGTRMPPKNF | 176 | Q86XS8 | |
| SPPAEFMRMIGNDKQ | 1056 | O60674 | |
| KPGMTMSCAKLPQNI | 666 | P29074 | |
| NETKSPGVMDNPLVM | 676 | P12883 | |
| ISTQGPKPMRSSQLM | 606 | Q99743 | |
| PKPMRSSQLMQSSGR | 611 | Q99743 | |
| NSSSAPMPVLLMGQA | 721 | Q99743 | |
| DGIPSRQRTPKINMM | 126 | Q9UJX3 | |
| TSQMPKGVLNMSLTP | 311 | P53677 | |
| KRLVAMNMPLNSDGT | 1506 | O60840 | |
| LKPASSSNPMDGMDN | 506 | Q6P3S6 | |
| NSKLLMMPSVNKSSP | 461 | Q92585 | |
| PTLGTLTPLNASMQM | 10501 | Q8WXI7 | |
| LTPLNASMQMASTIP | 10506 | Q8WXI7 | |
| RAKLMIPMDAQSNNP | 1231 | P43146 | |
| EQSDMPKGRPNTMNN | 161 | Q6N063 | |
| SKANFSIGPMMPVLA | 81 | P43632 | |
| VPSRNTSKQMNLNPM | 531 | Q71F56 | |
| NPQNVPFSQRSEMMK | 456 | Q0VAK6 | |
| PFSQRSEMMKKPSQA | 461 | Q0VAK6 | |
| AASKMQGPLGNPENM | 396 | Q5JYT7 | |
| ASTAGMILPKMPDFN | 216 | P50219 | |
| MILPKMPDFNSQAQS | 221 | P50219 | |
| TAPMDNTFLMVKPNG | 841 | Q5T655 | |
| MMRPNASQPGGAKDS | 1101 | Q5JU85 | |
| LGMDMTTAPRSKSQQ | 226 | Q9UPA5 | |
| DKMIRNPNSLKAMAP | 881 | P29323 | |
| QQMPSLRESPMTLKE | 841 | Q9UHC1 | |
| MSLQKLMEPEAGTNR | 1 | P47893 | |
| MSLQKLMEPEAGTNR | 1 | P47888 | |
| LDQQPIPMMDRNKAA | 751 | P35913 | |
| LSQFNLPGPSMMRSN | 1486 | Q8IVL0 | |
| KDRMMQKPGSNAPVG | 81 | Q8NHU0 | |
| RMNPKAITAPQMFGR | 2156 | Q96JB1 | |
| MSKNMLETSPQSLPQ | 431 | O15409 | |
| GLSPTPFMNSNLMGK | 96 | Q99081 | |
| SKMEPAAVPPQAMNS | 1336 | Q9ULK4 | |
| MGTDPEPAMRNKADQ | 2326 | Q6KC79 | |
| RKFIPDPQGSNMMFA | 171 | P35354 | |
| TAQIMQLPPGMKNAQ | 581 | A0A1B0GV03 | |
| LRMSPDAMNALFKPT | 441 | O43301 | |
| MVMGPNTVGKASQPS | 146 | Q96PU9 | |
| LLMVSAPNNPTVSGM | 46 | O75694 | |
| MLMSAKQTRAAPEAP | 16 | P51843 | |
| SQIMSGTLPMSQAPL | 226 | Q8IZL2 | |
| RMTPPKQMLSQQGPQ | 676 | Q14686 | |
| NSSPPLNKMNSMNKL | 461 | Q9H3D4 | |
| NIPMSVNDIVKPGMR | 276 | Q9UDY4 | |
| GSSMARMEASQPAPK | 941 | Q711Q0 | |
| KDRMMQKPGSNAPVG | 81 | Q5HYN5 | |
| KDRMMQKPGSNAPVG | 81 | P0DMV2 | |
| PENLASLMKGMASSP | 231 | Q14781 | |
| SMRPQVKSLGMNDTR | 2896 | Q9UFH2 | |
| NLIMGMDDNHPRPKS | 1981 | Q8TD57 | |
| KRLVGMNMPLNSDGT | 1446 | Q13698 | |
| KPEGPIQAMMAQSQS | 401 | O00512 | |
| RPGGSDMLPAQQKMV | 751 | O00512 | |
| KDRMMQKPGSNAPVG | 81 | Q5DJT8 | |
| MTRFQNMLRNSLPTP | 236 | Q01740 | |
| METRSPGLNNMKPQS | 1 | Q9BV73 | |
| MKSDTPSMLNPANVP | 746 | Q9NX05 | |
| MKNQLRGPPARAHMS | 1 | Q16829 | |
| AMQPKTTTANLMIRP | 3116 | Q0VDD8 | |
| NPFKLMIGSSNAMGR | 166 | Q9P267 | |
| KDRMMQKPGSNAPVG | 81 | P0DMV1 | |
| RSASKMFPSMDPQRG | 241 | Q9ULL0 | |
| EGNKTTMASPQLMPL | 16 | P35367 | |
| MKATESGAQSAPLPM | 6 | Q02790 | |
| FNRPSKIQENALPMM | 111 | Q9NUU7 | |
| PMGSQVSSMLKLALQ | 256 | Q8IY34 | |
| MNPKAITAPQMFGRL | 2291 | Q8TE73 | |
| AMQGMPVRNTGSPKS | 446 | Q9BTC8 | |
| QMPMGAVLGEPNKTT | 2106 | P0C091 | |
| AMKQAPQATSGLMEP | 66 | O14994 | |
| NMKTQPPLSRMNREE | 31 | Q96KN7 | |
| SANIKTPMMSVPVLN | 1256 | O95602 | |
| MNFNMSSSRGPLPVK | 136 | Q96E39 | |
| MAMPTQIPADGDTQK | 6 | Q6ZU15 | |
| LCSPSMKNINPLTAM | 646 | Q969F9 | |
| MGSGLMNLPPSILNN | 201 | Q9P2K5 | |
| APARGNMMSTSKPLA | 16 | A0PJY2 | |
| QRMFPMDSKPSLLNP | 896 | O75376 | |
| GLPNSKAGRMEPMNS | 921 | Q9Y6Q9 | |
| SAFPQQLTMKMLESP | 216 | Q5T5P2 | |
| KDIMLANQPSPRMTS | 536 | Q9H0K1 | |
| PNINTRMFQPMKNLS | 366 | Q8WXD0 | |
| NTMRTSLGPNGLDKM | 46 | P48643 | |
| ERKPPLFNMNAMSAL | 216 | Q9H2K8 | |
| NLPIKMSMGRVTPGQ | 371 | Q8WU76 | |
| PNDKTNIQGMTGTPM | 251 | P61371 | |
| GNSLQDTKAPMMPLS | 176 | Q9BSU1 | |
| PTSMLPPLQTMKANQ | 101 | A0A1W2PS18 | |
| MPSSPKQARKMSIQD | 201 | Q86SQ0 | |
| KMTPSNMAIVLGPNL | 396 | Q17R89 | |
| GQMKQPLQANMPSIS | 2211 | P25054 | |
| ALNMNGLAAAPMTPT | 301 | Q9BZC1 | |
| PRMASMNKPAFQAIR | 1536 | Q8N3C0 | |
| PSKPIPGMTLQESMN | 161 | Q8NHS4 | |
| ALGLPMRGMSNNTPQ | 81 | Q9NZN8 | |
| NISGMKERLSNMQTP | 176 | Q86WR6 | |
| TGLKMAMERSLNPIN | 2086 | A4UGR9 | |
| PRSPMGKENMVTFSN | 401 | Q7Z2D5 | |
| AVPTKNPDGTMNLMN | 26 | P63279 | |
| MAGNKSTPRASIRPM | 1686 | P12270 | |
| AVPMKPMSINSNLLG | 26 | Q9UH03 | |
| MSNVTLRKMSPTGNE | 1 | O95171 | |
| QNLINACTKDMPPMG | 781 | Q9H2E6 | |
| NISIMPSSLQMKTPE | 36 | Q7Z6J8 | |
| QNPDTLSAMSNPRAM | 446 | Q9UMX0 | |
| MQAAGLGRMKPNTLV | 871 | P55011 | |
| MQRNLGTEPKMAPQE | 276 | Q13426 | |
| RGQAQIPKLMSNMRP | 851 | Q9H0D6 | |
| MKVSSPPPTIMQQNK | 1501 | Q9HBL0 | |
| DPRKAMLSQMNVTAP | 201 | P46937 | |
| PRARKSMSLDMGQPS | 2516 | P21359 | |
| KPMMPQESLNGTGCR | 706 | Q5JSZ5 | |
| REPMNLASQMNKPGM | 306 | Q8N9R8 | |
| NSLPGLMMDLRNKGV | 401 | Q9NRW7 | |
| TLAMVSRQMGDSKPP | 711 | P78364 | |
| KMVIQGPSSPQGEAM | 1106 | Q12888 | |
| DSNMDLMPGILKQPS | 1286 | Q86X10 | |
| SNRAELMKLPMIPSS | 896 | Q9BZ95 | |
| MEGLTLKRNPMNVSS | 466 | Q08AG5 | |
| ERSTQGPLQMLQDMK | 241 | Q9Y577 | |
| LTPGKSPMNVMNVEN | 696 | Q9BY31 | |
| GMANLLTGPKRNLMA | 286 | Q99536 | |
| ELTMPSSVLKQGPMQ | 691 | Q9ULT0 | |
| LSFEVGAPMSPKMSN | 1081 | Q96JM2 | |
| IQKLMAQSGMSQPDP | 281 | Q9Y6M0 | |
| SKNISLMMNFQPPSK | 811 | Q6UXY8 | |
| PSGEKQVPTLMMDTQ | 121 | Q9UL62 | |
| SPTQEKRMLPSGMAS | 126 | Q5QJ38 | |
| TVLKVPRSMTDPQNM | 281 | Q6NUS6 | |
| GEPSMSLQSMKAQPK | 156 | O43309 | |
| LNNDGLSPLMMAAKT | 366 | Q9HBA0 | |
| FQPSLASSGMNKMLP | 316 | Q5VZL5 | |
| NLPMRGMPASSLQKE | 596 | Q9BVV6 | |
| LNLSSPNPMENKGMP | 381 | Q9UPQ9 | |
| QSSQPVLSQKPMGTM | 3371 | O14686 | |
| MQFQGMKRKASSPVP | 281 | Q99538 | |
| NDGTRPKMTPEQMAK | 1046 | Q9UM54 | |
| SPPSTLNAQMLNGMI | 261 | Q9Y2G1 |